Klinik der malignen Lymphome

  • J. P. Obrecht
Part of the Handbuch der Inneren Medizin book series (INNEREN, volume 2 / 7)

Zusammenfassung

Der Autor, der sich mit der „Klinik der malignen Lymphome“zu befassen hat, begegnet speziellen Schwierigkeiten, die mit der Semantik der einzelnen Spielarten und Formen von Lymphomen zusammenhängen und den jeweiligen Stand unserer Kenntnisse widerspiegeln. In der älteren Literatur z.B. wird ausschließlich die alte deutsche Klassifizierung der Non-Hodgkin-Lymphome benutzt; später, ab 1956 folgt die Rappaportsche Einteilung mit einer differenten Nomenklatur, die bis heute vor allem das angelsächsische Schrifttum bestimmt. In den letzten Jahren wurden neuere Klassifikationen eingeführt, die auf einer verfeinerten Diagnostik der Zellen des lymphatischen Systems und deren malignen Abkömmlingen beruhen; sie sind mit den Namen Dorfman (1974); Bennett et al. (1974); Lukes u. Collins (1974); Lennert et al. (1975) sowie Mathé et al. (1976) verbunden. Die sog. Kieler Klassifikation, die von Lennert et al. (1975) konzipiert wurde, hat Stein im Kapitel „Systematik der Non-Hodgkin-Lymphome“ ausführlich dargestellt.

Literatur

  1. Aaro, L.A., Symmonds, R.E., Dockert, M.B.: Sarcoma of the uterus. Amer. J. Obstet. Gynec. 94, 101–109 (1966).PubMedGoogle Scholar
  2. Abbatucci, I.S., van der Werf-Messing, B.: EORTC Radio-Chemotherapy Cooperative Group. Clinical trial using radiotherapy and chemotherapy in non-Hodgkin’s lymphoma. Protocol. 20751 (1975).Google Scholar
  3. Abbott, K.H., Adson, A.W.: Primary intracranial lymphosarcoma: Report of 2 cases and review of literature. Arch. Surg. 47, 147–159 (1943).Google Scholar
  4. Abele, R., Alberto, P., Germano, G., Obrecht, J.P., Wagenknecht, L.: Combinaison simultanée d’adriamycine, de bléomycine, de cyclohexyl-chloroéthyl-nitrosourée et de diméthyl-triazénoimidazole-carboxamide dans le traitement des lymphomes hodgkiniens ou non. Schweiz, med. Wschr. 106, 961–963 (1976).Google Scholar
  5. Abell, M.R., Holtz, F.: Testicular and paratesticular neoplasms, in patients 60 years of age and older. Cancer 21, 852–870 (1968).PubMedGoogle Scholar
  6. Abeloff, M.D.: Clinical management of ureteral obstruction secondary to mal. lymphoma. Johns Hopk. med. J. 134, 34 (1974).Google Scholar
  7. Abeloff, M.D., Waterbury, L.: Pure red blood cell aplasia and chronic lymphocytic leukemia. Arch, intern. Med. 134, 721–724 (1974).Google Scholar
  8. Abeshouse, B.S., Tiongson, A., Goldfarb, M.: Bilateral tumors of testicles — Review of literature and report of case of bilateral simultaneous lymphosarcoma. J. Urol. (Baltimore) 74, 522–532 (1955).Google Scholar
  9. Abrams, H.L., McNeil, B.J.: Medical implications of computed tomography (first of two parts). New Engl. J. Med. 298, 255 (1978).PubMedGoogle Scholar
  10. Ackerman, L.V., Regato, J.A., del: Cancer: diagnosis, treatment and prognosis (ed. 4), p. 289. St. Louis: Mosby 1970.Google Scholar
  11. Adair, F.E., Herrmann, J.B.: Primary lymphosarcoma of breast. Surgery 16, 836–853 (1944).Google Scholar
  12. Adams, J.H., Jackson, J.M.: Intracerebral tumours of reticular tissue. — The problem of microgliomatosis and reticuloendothelial sarcomas of the brain. J. Path. Bact. 91, 369–381 (1966).PubMedGoogle Scholar
  13. Adelson, H.T.: Macroglobulinemia of Waldenstrom apparently associated with two paraproteins. New Engl. J. Med. 265, 20–23 (1961).PubMedGoogle Scholar
  14. Adler, S. et al.: Gallium 67 citrate scanning for localization and staging of lymphomas. J. Nucl. Med. 16, 255–260 (1975).PubMedGoogle Scholar
  15. Adler, S., Stutzman, L., Sokal, J.E., Mittelman, A.: Splenectomy for hematologic depression in lymphocytic lymphoma and leukemia. Cancer 35, 521 (1975).PubMedGoogle Scholar
  16. Adler, S.S., Shetty, J., Golomb, H.M.: Coexistence of leukemic reticuloendotheliosis and histiocytic lymphoma: a case report. Cancer 43, 1872 (1979).PubMedGoogle Scholar
  17. Advani, S.H., Khare, A.G., Nadkarni, J.J., Bhisey, A.N., Nadkarni, J.S., Talvalker, G.V.: A case of Sézary syndrome with non-rosetting cells and unusual cytogenetic findings. Acta haemat. (Basel) 61, 194–197 (1979).Google Scholar
  18. Advani, S.H., Talwalkar, G.V., Nadkarni, J.S., Nadkarni, J.J., Sirsat, S.M., Srinivasan, V.: Hairy-cell leukaemia. Indian J. Cancer 13, 283–287 (1976).PubMedGoogle Scholar
  19. AhlstrÖm, S., Lindgren, M., Olivecrona, H.: Radiologic treatment of orbital lymphoma. Acta radiol. (Therapy) 3, 441–448 (1965).Google Scholar
  20. Ahmann, D.L., Kiely, J.M., Harrison, E.G., Jr., et al.: Malignant lymphoma of the spleen: A review of 49 cases in which the diagnosis was made at splenectomy. Cancer 19, 461–469 (1966).PubMedGoogle Scholar
  21. Airlie House, Warrenton, Virginia: Invitational workshop for the planning of retrospektive and prospektive studies to delineate optimal classifications of the non-Hodgkin’s lymphomas. Sept. 4–5 (1975).Google Scholar
  22. Aisenberg, A.C.: Studies on delayed hypersensitivity in Hodgkin’s disease. J. clin Invest. 41, 1964–1970 (1962).PubMedGoogle Scholar
  23. Aisenberg, A.C.: Malignant lymphoma. New Engl. J. Med. 288, 883–890, 935–941 (1973).PubMedGoogle Scholar
  24. Aisenberg, A.C., Bloch, K.J., Long, J.C.: Cell surface immunoglobulins in chronic lymphocytic leukemia and allied disorders. Amer. J. Med. 55, 184 (1973).PubMedGoogle Scholar
  25. Aisenberg, A.C., Cohen, R.B.: Malignant lymphoma and renal impairment. New Engl. J. Med. 279, 648–656(1968).Google Scholar
  26. Aisenberg, A.C., Goldman, J.M., Raker, J.W.: Spleen involvement at the onset of Hodgkin’s disease. Ann. intern. Med. 74, 544–547 (1971).PubMedGoogle Scholar
  27. Aisenberg, A.C., Long, J.C.: Lymphocyte surface characteristics in malignant lymphoma. Amer. J. Med. 58, 300–306 (1975).PubMedGoogle Scholar
  28. Aisenberg, A.C., Long, J.C.: A 54-year-old man with nodular lymphoma and circulating atypical lymphocytes. New Engl. J. Med. 301, 1332 (1979).Google Scholar
  29. Aisenberg, A.C., Long, J.C., Wilkes, B.: Chronic lymphatic leukemia cells: Rosette formation and adherence to nylon fiber columns. J. nat. Cancer Inst. 52, 13–17 (1974).PubMedGoogle Scholar
  30. Aisenberg, A.C., Wilkes, B.: Lymphosarcoma cell leukemia: The contribution of cell surface study to diagnosis. Blood 48, 707–715 (1976).PubMedGoogle Scholar
  31. Albahary, C., Ripault, J., Guillaume, J., Legrand, P., Martin, S.: La reticulose histiolymphocytaire avec myelofibrose. Presse méd. 35, 1531 (1970).Google Scholar
  32. al-Bahrani, Z.R., Bakir, F.: Primary intestinal lymphoma: A challenging problem in abdominal pain. Ann. roy. Coll. Surg. Engl. 49, 103–113 (1971).Google Scholar
  33. Albarracin, N.S., Bain, B.: Plasmalemmal configurations assumed by lymphocytes in vitro. Amer. J. clin. Path. 60, 628–635 (1973).Google Scholar
  34. Albrechtsson, U., Tylen, U.: Angiography in reticulum cell sarcoma. Acta Radiol. Diagn. 18, 210–216(1977).Google Scholar
  35. Alcorn, F.S., Mategrano, V.C., PetaŚnick, J.P., Clark, J.W.: Contributions of computed tomography in the staging and management of malignant lymphoma. Radiology 125, 717–723 (1977).PubMedGoogle Scholar
  36. Alderson, W.E., Barrow, G.I., Turner, R.L.: Sézary syndrome. Brit. med. J. 1, 256–260 (1955).PubMedGoogle Scholar
  37. Aledort, L.M., Hodges, M., Brown, J.A.: Irreversible renal failure due to malignant lymphomas. Ann. intern. Med. 65, 117–121 (1966).PubMedGoogle Scholar
  38. Alexander, J.W., Altemeier, W.A.: Association of primary neoplasms of the small intestine with other neoplastic growths. Ann. Surg. 167, 958–964 (1968).PubMedGoogle Scholar
  39. Alexanian, R.: Monoclonal gammopathy in lymphoma. Arch, intern. Med. 135, 62–66 (1975).Google Scholar
  40. Alfidi, R.J., Haaga, J., Meaney, R.F., MacIntyre, W.J., Gonzalez, L., Tarar, R., Zelch, M.G., Boller, M., Cook, S.A., Jelden, G.: Computed tomography of the thorax and abdomen; a preliminary report. Radiology 117, 257 (1975).PubMedGoogle Scholar
  41. Alibert, J.L.M.: Description des maladies de la Peau observées à l’hôpital St-Louis, et exposition des meilleures méthodes suivies pour leur traitement, p. 157. Paris: Barrois l’Aine et Fils 1806.Google Scholar
  42. Alibert, J.M.L.: Monographie des dermatoses, 2nd ed., p. 413. Baillière 1835.Google Scholar
  43. al-Khateeb, A.K.: Primary malignant lymphoma of the small intestine. Int. Surg. 54, 295–300 (1970).Google Scholar
  44. Allansmith, M., Chandor, S.: Asymptomatic monoclonal IgA hyperglobulinemia. — A three year study. Amer. J. Med. 265, 20–23 (1961).Google Scholar
  45. Allen, A.W., Donaldson, G., Sniffen, R.C.: Primary malignant lymphoma of the gastrointestinal tract. Ann. Surg. 140, 428–438 (1954).PubMedGoogle Scholar
  46. Allen, L.W., Strum, S.B., Ultmann, J.E., et al.: The staging of lymphoma, in: Ultmann, J.E., Griem, M.L., Kirsten, W.H. et al. (eds.), Current concepts in the management of leukemia and lymphoma, pp. 13–46. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  47. Allison, R.S., Gordon, D.S.: Reticulosis of the nervous system simulating acute infective polyneuritis. Lancet 1955 II, 120–122.Google Scholar
  48. Al-Saleem, T., Al-Bahrani, A.: Malignant lymphoma of the small intestine in Iraq. Cancer 31, 291 (1973).PubMedGoogle Scholar
  49. Al-Saleem, T., Harwick, R., Robbins, R. et al.: Malignant lymphomas of the pharynx. Cancer 26, 1383–1387 (1970).PubMedGoogle Scholar
  50. Altman, J., Winkelmann, R.K.: Lymphosarcoma of the skin and testis. Arch. Derm. 82, 943–947 (1960).PubMedGoogle Scholar
  51. Ambrose, J.: Computerized transverse axial scanning (tomography): Part 2. Clinical application. Brit. J. Radiol. 46, 1023 (1973).PubMedGoogle Scholar
  52. American Cancer Society: ‘75 Cancer facts and figures. 1974.Google Scholar
  53. Ancalmo, N., King, T.D., Mills, N.L., Willis, G.: Lymphoma with large intracavitary metastasis to the heart: Report of a case. J. cardiovasc. Surg. (Torino) 17, 136–139 (1976).Google Scholar
  54. Anday, G.J., Goodman, J.R., Tishkoff, G.H.: An unusual cytoplasmic ribosomal structure in pathologic lymphocytes. Blood 41, 439 (1973).PubMedGoogle Scholar
  55. Anderson, T., Bender, R.A., Rosenoff, S.H., Brereton, H.D., Chabner, B.A., DeVita, V.T., Hubbard, S.P., Young, R.C.: Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin’s lymphoma patients. Cancer Treat. Rep. 61, 1017 (1977).PubMedGoogle Scholar
  56. Anderson, T., Rosenoff, S., Bender, R., Gold, G.L., Young, R.C.: Peritoneoscopy: A useful tool in restaging lymphoma patients. ASCO Abstr. 17, 268. Toronto 1976.Google Scholar
  57. Anderson, W.A., Trantalis, J., Kang, Y.H.: Ultrastructural localization of endogenous mammary gland peroxidase during lactogenesis in the rats. J. Histochem. Cytochem. 23, 296 (1975).Google Scholar
  58. Anderson, T., DeVita, V., Bender, R., Mann, R., Chabner, B., Young, R.: Nodular lymphomas (NL): An important correlation of survival with complete remission induction. Proc. Amer. Soc. Clin. Onkol. 1977, p. 326.Google Scholar
  59. Andreev, V.C., Zlatkov, N.B.: Systemic lupus erythematosus and neoplasia of the lymphoreticular system. Brit. J. Derm. 80, 503 (1968).PubMedGoogle Scholar
  60. Andrews, G.A., Edwards, C.L.: Tumor scanning with gallium 67. J. Amer. med. Ass. 233, 1100(1975).Google Scholar
  61. Andrews, J.T., et al.: Value of Gallium 67 scanning in upper abdominal lymphomas. Med. J. Aust. 2, 170–172 (1976).PubMedGoogle Scholar
  62. D’Angio, G.J., Mitus, A., Evans, A.E.: The superior mediastinal syndrome in children with cancer. Amer. J. Roengenol. 93, 537–544 (1965).Google Scholar
  63. Ansari, A., Lundquist, V.P., Azad, M.: Bone scintiscan and malignant lymphoma. Ann. intern. Med. 85, 684–685 (1976).PubMedGoogle Scholar
  64. Antoniades, J., Brady, L.W., Lightfoot, D.A.: Lymphangiographie demonstration of the abscopal effect in patients with malignant lymphomas. Int. J. Radiât. Oncol. Biol. Phys. 2, 141–147 (1977).PubMedGoogle Scholar
  65. Appen, R.E.: Posterior uveitis and primary cerebral reticulum cell sarcoma. Arch. Ophthal. 93, 123–124 (1975).PubMedGoogle Scholar
  66. Arends, T., Coonrad, C.V., Rundles, R.W.: Serum proteins in Hodgkin’s disease and malignant lymphoma. Amer. J. Med. 16, 833 (1954).PubMedGoogle Scholar
  67. Ariel, L.M., Molander, D.: Hepatic gammascanning. An aid in determining treatment policies for cancer involving the liver. Amer. J. Surg. 118, 5–14 (1969).PubMedGoogle Scholar
  68. Armitage, J.O., Dick, F.R., Corder, M.P.: Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer (Philad.) 41, 422–427 (1978).Google Scholar
  69. Armstrong, D., Myers, W.P.: Renal failure incident to reticulum cell sarcoma of the kidneys. Ann. intern. Med. 65, 109–116 (1966).PubMedGoogle Scholar
  70. Armstrong, D., Young, L.S., Meyer, R.D., et al.: Infectious complications of neoplastic disease. Med. Clin. N. Amer. 55, 729 (1971).PubMedGoogle Scholar
  71. Arnold, H.S., Meese, E.H., D’Amato, N.A., et al.: Localized Hodgkin’s disease presenting as a sternal tumor and treated by total sternectomy. Ann. thorac. Surg. 2, 87–93 (1966).PubMedGoogle Scholar
  72. Arseneau, J.G., Aamodt, R., Johnston, G.S., Canellos, G.P.: Evidence for granulocytic incorporation of Gallium-67 in chronic granulocytic leukemia. J. Lab. clin. Med. 84, 496 (1974).Google Scholar
  73. Arseneau, J.C., Canellos, G.P., Banks, P.M., et al.: American Burkitt’s lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Amer. J. Med. 58, 314–321 (1975).PubMedGoogle Scholar
  74. Arzt, L.: Die Mykosis fungoides in der europäischen und amerikanischen Forschung. Hautarzt 2, 519–523 (1951).Google Scholar
  75. Astaldi, G., Girando, L.C., Marsani, F.: Lymphocytes in reticulum-cell sarcoma. Lancet 1968 II, 410.Google Scholar
  76. Astaldi, G., Meardi, G., Taverna, P.L., Yalcin, B.: Our preliminary experience on the use of peptichemio in leukemia and malignant lymphoma. In: Leukämie und maligne Lymphome, p. 379. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  77. Atkin, N.B.: Cytogenetic aspects of malignant transformation. Basel-München-Paris-London-New York-Sydney: Karger 1976.Google Scholar
  78. Aulbert, E., Gebhardt, A., Schulz, E., Haubold, U.: Mechanism of 67Ga accumulation in normal rat liver lysosomes. Nucl. Med. (Stuttg.) 15, 185 (1976).Google Scholar
  79. Aur, R.J.A., Hustu, H.O., Simone, J.V., et al.: Therapy of localized and regional lymphosarcoma of childhood. Cancer 27, 1328–1351 (1971).PubMedGoogle Scholar
  80. Aur, R.J.A., Hustu, H.O., Verzosa, M.S., Wood, A., Simone, J.V.: Comparison of two methods of preventing central nervous system leukemia. Blood 42, 349 (1973).PubMedGoogle Scholar
  81. Austad, W.I., Cornes, J.S., Gough, K.R., McCarthy, C.F., Read, A.E.: Steatorrhea and malignant lymphoma. The relationship of malignant tumors of lymphoid tissue and celiac disease. Amer. J. digest. Dis. 12, 475–490 (1967).Google Scholar
  82. Axelsson, V., Bachmann, R., Hallen, J.: Frequency of pathologica 1 proteins (M-components) in 6,995 sera from an adult population. Acta med. scand. 179, 235–247 (1966).PubMedGoogle Scholar
  83. Azar, H.A., Hill, W.T., Osserman, E.F.: Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins. Amer. J. Med. 23, 239–249 (1957).PubMedGoogle Scholar
  84. Azzopardi, J.G., Evans, D.J.: Malignant lymphoma of parotid associated with Mikulicz disease (benign lymphoepithelial lesion). J. clin. Path. 24, 744–752 (1971).PubMedGoogle Scholar
  85. Azzopardi, J.G., Menzies, T.: Primary malignant lymphoma of the alimentary tract. Brit. J. Surg. 47, 358–366 (1960).PubMedGoogle Scholar
  86. Baccaredda, A.: Reticulohistiocytosis cutanea hyperplastica benigna cum melanodermia. Arch. Derm. Syph. (Berl.) 179, 209 (1939).Google Scholar
  87. Bach, F.H., Rood, J.J. van: The major histocompatibility complex. — Second of three parts. New Engl. J. Med. 295, 872–878 (1976).PubMedGoogle Scholar
  88. Bagley, C.M., Jr., DeVita, V.T.,Jr., Berard, C.W., Canellos, G.P.: Advanced lymphosarcoma. — Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann. intern. Med. 76, 227–234 (1972).PubMedGoogle Scholar
  89. Bagley, Ch.M., Thomas, L.B., Johson, R.E., Chretien, P.B., DeVita, V.T.: Diagnosis of liver involvement by lymphoma: Results in 96 consecutive peritoneoscopies. Cancer 31, 840–847 (1973).PubMedGoogle Scholar
  90. Bailey, R.J., Jr., Burgert, E.O., Jr., Dahlin, D.C.: Malignant lymphoma in children. Pediatrics 28, 985–992 (1961).PubMedGoogle Scholar
  91. Bajo, Gomez R., Prados Madrona D., Nunez, Roldan A., et al.: Linfoma primario de bazo. Sangre (Barcelona) 20, 487–492 (1975).Google Scholar
  92. Bakshi, S., Bender, M.A.: Use of gallium-67 scanning in the management of lymphoma. J. Surg. Oncol. 5, 539–549 (1973).PubMedGoogle Scholar
  93. Baldini, M.: Idiopathic thrombocytopenic purpura and the ITP syndrome. Med. Clin. N. Amer. 56, 47–64 (1972).PubMedGoogle Scholar
  94. Balikian, J.P., Nassar, N.T., Shamma’a, M.H., et al.: Primary lymphoma of the small intestine including the duodenum. A roentgen analysis of twenty-nine cases. Amer. J. Roentgenol. 107, 131–141 (1969).PubMedGoogle Scholar
  95. Baltaxe, H.A., Constable, W.C.: Mediastinal lymph node visualisation in the absence of intrathoracic disease. Radiology 90, 94 (1968).PubMedGoogle Scholar
  96. Banerjee, D., Hamdy, H., Bormanis, J., Walker, T., Richter, M.: Leukemic reticuloendotheliosis: Polyclonal surface immunoglobulin on “hairy” cells. Cancer 41, 1804–1810 (1978).PubMedGoogle Scholar
  97. Banfi, A., Bonadonna, G., Carnevali, G., Oldini, C., Salvini, E.: Preferential sites of involvement and spread in malignant lymphomas. Europ. J. Cancer 4, 319–324 (1968).Google Scholar
  98. Banfi, A., Bonadonna, G., Carnevali, G., et al.: Lymphoreticular sarcoma with primary involvement of Waldeyer’s ring: Clinical evaluation of 225 cases. Cancer 26, 341–351 (1970).PubMedGoogle Scholar
  99. Banfi, A., Bonadonna, G., Guraggi, H., et al.: Clinical staging and treatment of lymphosarcoma and reticulum cell sarcoma. Tumori 51, 153–178 (1965).PubMedGoogle Scholar
  100. Banfi, A., et al.: Malignant lymphomas: further studies on their preferential sites of involvement and possible mode of spread. Lymphology 2, 130–138 (1969).PubMedGoogle Scholar
  101. Banfi, A., Bonadonna, G., Ricci, S., Milani, F., Molinari, R., Monfardini, S., Zucali, R.: Malignant lymphomas of Waldeyer’s ring: Natural history and survival after radiotherapy. Brit. med. J. III, 140 (1972).Google Scholar
  102. Bansal, S., Brady, L.W., Olsen, A., et al.: The treatment of metastatic spinal cord tumors. J. Amer. med. Ass. 202, 686–688 (1967).Google Scholar
  103. Barbieri, A. De, Chiappino, G., Vittorio, P. Di, Golferini, A., Maugeri, M., Mistretta, A.P., Perrone, F., Tassi, G.C., Temelcou, O., Zapelli, P.: II peptichemio; sintesi di ricerche farmaco-logiche, morfologiche, biochimiche e biologico-molecolari; in: Peptichemio, pp. 13–54. Milano: Istituto Sieroterapico Belfanti 1972.Google Scholar
  104. Barbieri, A. De, Tassi, G.C., Mistretta, A.P.: Ricerche sul meccanismo d’azione di un nuovo antimitotico multipeptidico. Tumori 58, 257–260 (1972).Google Scholar
  105. Barbieri, A. De, Vittorio, P. Di, Golferini, A., Maugeri, M., Mistretta, A.P., Perrone, F., Tassi, G.C., Temelcou, O., Zapelli, P.: Investigations on the effect of antitumor peptides and mixtures of the same; in Leukämien und maligne Lymphome. Pathophysiologie Klinik, Chemo- und Immunotherapie, pp. 20–25. Wien: Urban & Schwarzenberg 1972.Google Scholar
  106. Barclay, J.K.: Reticulum cell sarcoma: Report of case. J. oral Surg. 29, 734–736 (1971).PubMedGoogle Scholar
  107. Barcos, M.P., Lukes, R.J.: Malignant lymphoma of convoluted lymphocytes. — A new entity of possible T-cell type. Conflicts in childhood Cancer. An evaluation of current management, Vol. 4 (L.F. Sinks and J.O. Godden, eds.), pp. 147–178. New York: Alan R. Liss, Inc. 1975.Google Scholar
  108. Bargman, H., Coupe, R.L.: Sezary’s syndrome. Report of a case showing peripheral neuropathy and bone marrow fibrosis. Arch. Derm. 114, 1360–1362 (1978).PubMedGoogle Scholar
  109. Barkin, J., Vining, D., Miale, A., et al.: Computerized tomography, diagnostic ultrasound, and radionuclide scanning: comparison of efficacy in diagnosis of pancreatic carcinoma. J. Amer. med. Ass. 238, 2040–2042 (1977).Google Scholar
  110. Baron, M.G., Whitehouse, W.M.: Primary lymphosarcoma of the lung. Amer. J. Roentgenol. 85, 294–308 (1961).PubMedGoogle Scholar
  111. Barr, M., Fairley, G.H.: Circulating antibodies in reticuloses. Lancet 1961 I, 1305.Google Scholar
  112. Barrett, A., Brigden, D., Roberts, J., et al.: Antilymphocyte globulin in the treatment of advanced Sézary syndrome. Lancet 1976 I, 940–941.Google Scholar
  113. Barrowman, J. A., Pollock, D.L., Taylor, J.H., Wright, J.T.: Small intestinal lymphoma presenting as malabsorption after vagotomy and gastrojejunostomy. Brit. J. clin. Pract. 30, 21–22 (1976).PubMedGoogle Scholar
  114. Bartolucci, A., Durant, J.R., Gams, R.A.: Prognostic factors in non-Hodgkin’s lymphoma: A multivariate analysis of over 300 cases. Proc. Amer. Soc. Clin. Onkol. 1977, p. 304.Google Scholar
  115. Basex, A., Parant, M., Basex, J.: Mycosis fongoide. Protéine monoclonale IgM Bull. Soc. franc. Derm. Syph. 82, 149–150 (1975).Google Scholar
  116. Baum, S., Bron, K.M., Wexler, L., et al.: Lymphangiography cavography, and urography: comparative accuracy in the diagnosis of pelvic and abdominal metastases. Radiology 81, 207–218 (1963).PubMedGoogle Scholar
  117. Bazin, E.: Mycosis. Dictionnaire encyclopédique des sciences médicales publié, sous la direction de Raige-Delorme et A. Dechambre Sér. 2, 11, 180 (1876).Google Scholar
  118. Beachey, E.H., Hashimoto, K., Burkett, L.L.: Histiocytic leukemia. Ultrastructure and phagocytic capacity of hairy cells. Clin. Res. 17, 530 (1969).Google Scholar
  119. Beahrs, O.H., Woolner, L.B., Carbeth, S.W., Devine, K.D.: Surgical management of parotid lesions — A review of 760 cases. Arch. Surg. 80, 890–904 (1960).PubMedGoogle Scholar
  120. Beard, M.E.J., Crowther, D., Galton, D.A.G., Guyer, R.J., Hamilton, F.G., Kay, H.E.M., Knapton, P.J., Malpas, J.S., Scott, B.R.: L-Asparaginase in treatment of acute leukemia and lymphosarcoma. Brit. med. J. 1, 191 (1970).PubMedGoogle Scholar
  121. Beck, W.C., Reganis, J.C.: Primary lymphoma of lung. J. thorac. Surg. 22, 323–328 (1951).PubMedGoogle Scholar
  122. Bednar, B.: The so called immunologic classification of non Hodgkin malignant lymphomas (Czech), Cspat 11, 161–168 (1975).Google Scholar
  123. Bekerman, C., Hoffer, P.B.: Salivary gland uptake of 67Ga-citrate following radiation therapy. J. nucl. Med. 17, 685–687 (1976).PubMedGoogle Scholar
  124. Benjamin, R.S., Wiernik, P.H., Bachur, N.R.: Adriamycin chemotherapy. Efficacy safety, and pharmacologic basis of anintermittent single high-dosage schedule. Cancer 33, 19 (1974).PubMedGoogle Scholar
  125. Benjamin, R.S., Wiernik, P.H., O’Connell, M.J., Chang, P., Sutherland, J.C.: A comparison of cyclophosphamide. Vincristine, and prednisone, (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma. Cancer 38, 1896–1902 (1976).PubMedGoogle Scholar
  126. Bennett, J.E.: Cryptococcal infections. In: Hoepisch, P. (ed.), Infectious diseases (1972).Google Scholar
  127. Bennett, M.H., Farrer-Brown, G., Henry, K., et al.: Classification of non-Hodgkin’s lymphomas. Lancet 1974 II, 405–406.Google Scholar
  128. Benstad, H.B.: Formation of granulocytes and macrophages in diffusion chamber cultures of mouse blood leukocytes. Scand. J. Haemat. 7, 279 (1970).Google Scholar
  129. Bentwich, Z., Kunkel, H.G.: Specific properties of human B and T lymphocytes and alterations in disease. Transplant. Rev. 16, 29–50 (1973).PubMedGoogle Scholar
  130. Berard, C.W.: Reticuloendothelial system: An overview of neoplasia. Internat. Academy of Pathology Monograph Nr. 18, pp. 310–317. Baltimore: Williams & Wilkins Co. 1975.Google Scholar
  131. Berard, C.W.: Current concepts of leukemia and lymphoma: Etiology, pathogenesis, and therapy. Ann. intern. Med. 85, 351–366 (1976).Google Scholar
  132. Berard, C.W., Dorfman, R.D.: Histopathology of malignant lymphomas. In: Rosenberg, S.A. (ed.), Clinics in hematology, Vol. 3, p. 39. Philadelphia: Saunders 1974.Google Scholar
  133. Berard, C.W., Jaffe, E.S., Braylan, R.C., et al.: Immunologic aspects and pathology of the malignant lymphomas. Cancer 42, 911–921 (1978).PubMedGoogle Scholar
  134. Berd, D., Cornog, J., DeConti, R.C., Levitt, M., Bertino, J.R.: Long term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy. Cancer 35, 1050–1054 (1975).PubMedGoogle Scholar
  135. Beretta, G., Spinelli, P., Rilke, F., Tancini, G., Canetta, R., Gennari, L., Bonadonna, G.: Sequential laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin’s disease. Cancer Treat. Rep. 60, 1231 (1976).PubMedGoogle Scholar
  136. Berg, B., Brandt, L.: The cytology, distribution and function of the neoplastic cells in leukemic reticuloendotheliosis. Scand. J. Haemat. 7, 428 (1970).PubMedGoogle Scholar
  137. Berg, J.W.: Primary lymphomas of the human gastrointestinal tract. Nat. Cancer Inst. Monogr. 32, 211–220(1969).PubMedGoogle Scholar
  138. Berger, C.L., Warburton, D.,Raafat, J., LoGerio, P., Edelson, R.: Cutaneous T-cell lymphoma: Neoplasm of T-cells with helper activity. Blood 53, 642–651 (1979).PubMedGoogle Scholar
  139. Berggreen, P.: Verlaufsweisen der Mycosis fungoides (unter besonderer Berücksichtigung der Atypien). Arch. Derm. Syph. (Berl.) 178, 501 (1939).Google Scholar
  140. Bergsagel, D.E., Brown, T.C., Reid, J.: The influence of chemotherapy on the management of non-Hodgkin’s lymphomata at the Princess Margaret Hospital: a comparison of the results from 1962–1964 with 1967–1969. Brit. J. Cancer 31, Suppl. II, 489 (1975).Google Scholar
  141. Bergsteinova, V., Lintner, R., Topol, O., Zabojova, E.: Unsere Erfahrungen bei der Therapie der Lympho- und Reticulosarcome. Radiobiol. Radiother. 8, 301 (1967).Google Scholar
  142. Berman, H.: Waldenstrom’s macroglobulinemia with lytic osseous lesions and plasma-cell morphology: Report of a case. Amer. J. clin. Path. 63, 397–402 (1975).Google Scholar
  143. Berry, G.R., Mathews, W.H.: Gastric lymphosarcoma and pseudolymphoma: Reappraisal of 12 cases of gastric lymphosarcoma. Canad. med. Ass. J. 96, 1312–1316 (1967).PubMedGoogle Scholar
  144. Berry, M.N.: The liver and lactic acidosis. Proc. roy. Soc. Med. 60, 1260–1262 (1967).PubMedGoogle Scholar
  145. Bertino, J.R.: Editorial: Hairy cell leukemia (leukemic reticuloendotheliosis): Chemotherapy for splenectomy failures. Blood 54, 297 (1979).PubMedGoogle Scholar
  146. Besa, E.C., Gardner, F.H.: Prolonged remission in a case of leukemic reticuloendotheliosis after etiocholanolone and prednisolone therapy. Blood 50, 183 (1977).Google Scholar
  147. Besnier, E., Hallopeau, H.: On the erythrodermia of mycosis fungoides. J. cutan. Genitourin Dis. 10, 453 (1892).Google Scholar
  148. Bessis, M.: Living blood cells and their ultrastructure. Berlin-Heidelberg-New York: Springer 1973.Google Scholar
  149. Best, C.N., Cook, P.B.: Case of mesenteric reticulo sarcoma associated with gluten sensitive steatorrhea. Brit. med. J. 2, 496–498 (1964).Google Scholar
  150. Best, J.J.K., Blackledge, G., Forbes, W.St.C., Todd, I.D.H., Eddleston, B., Crowther, D., Isherwood, I.: Computed tomography of abdomen in staging and clinical management of lymphoma. Brit. med. J. 1675 (1978).Google Scholar
  151. Bhansali, S.K., Cameron, K.M.: Primary malignant lymphoma of the bladder. Brit. J. Urol. 32, 440–454 (1960).Google Scholar
  152. Bilder, L., Hornova, J.: Lymphosarkom priusni zlazy pri sjögenove syndromu. Czas. stomat. 67, 441 (1967).Google Scholar
  153. Billingham, M.E., Rawlinson, D.G., Berry, P.F., Kempson, R.L.: The cytodiagnosis of malignant lymphomas and Hodgkin’s disease in cerebrospinal, pleural and ascitic fluids. Acta cytol. (Bait.) 19, 547–556 (1975).Google Scholar
  154. Biro, I., Varady, J., Szekely, L., Karcsay, I.: On the occurrence of cryoglobulinemia based on 9454 personal observations. Orv. Hetil. 104, 205 (1963).PubMedGoogle Scholar
  155. Bitran, J.D., Golomb, H.M., Ultmann, J.E., Sweet, D.L., Lester, E.P., Stein, R.S., Miller, J.B., Moran, E.M., Kinnealey, A.E., Vardiman, J.E., Kinzie, J., Roth, N.O.: Non-Hodgkin’s lymphoma, poorly differentiated lymphocytic and mixed cell types. Cancer 42, 88–95 (1978).PubMedGoogle Scholar
  156. Bitran, J.D., Kinzie, J., Sweet, D.L., Variakojis, D.,Griem, M.L., Golomb, H.M., Miller, J.B., Oetzel, N., Ultmann, J.E.: Survival of patients with localized histiocytic lymphoma. Cancer 39, 342–346(1977).PubMedGoogle Scholar
  157. Blatt, E., Page, I.H.: Hypertension and constriction of renal arteries in man: Report of case. Ann. intern. Med. 12, 1690–1699 (1939).Google Scholar
  158. Blaylock, W.K., Clendenning, W.E., Carbone, P.P., et al.: Normal immunologic reactivity in patients with the lymphoma mycosis fungoides. Cancer 19, 233–236 (1966).PubMedGoogle Scholar
  159. Block, J.R., Bronson, W.R., Bell, W.R.: Metabolic abnormalities of lactic acid in Burkitt-type lymphoma with malignant effusions. Ann. intern. Med. 65, 101–108 (1966).PubMedGoogle Scholar
  160. Block, S.B.: Lactic acidosis in malignancy and observations on its possible pathogenesis. Ann. N.Y. Acad. Sci. 230, 94–102 (1974).PubMedGoogle Scholar
  161. Bloedorn, F.G.: Treatment after excision of scalp lymphosarcoma. J. Amer. med. Ass. 218, 602 (1971).Google Scholar
  162. Blom, J.: Treatment of stage III and IV diffuse lymphocytic and histiocytic lymphoma with vincristine/prednisone/bleomycin/streptonigrin induction, cyclophosphamide/vincristine/prednisone maintenance with or without consolidation with vinblastine/CCNU/prednisone. Proc. Amer. Soc. Clin. Onkol. 1977, p. 332.Google Scholar
  163. Bloomfield, C.D.: Recognizing and evaluating non-Hodgkin’s lymphomas. Geriatrics 30, 56 (1975).PubMedGoogle Scholar
  164. Bloomfield, C.D., Gajl-Peczalska, K.J., Frizzera, G., Kersey, J.H., Goldman, A.I.: Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma. New Engl. J. Med. 301, 512 (1979).PubMedGoogle Scholar
  165. Bloomfield, C.D., Goldman, A., Dick, F., Brunning, R.D., Kennedy, B.J.: Multivariate analysis of prognostic factors in the non-Hodgkin’s malignant lymphomas. Cancer 33, 870 (1974).PubMedGoogle Scholar
  166. Bloomfield, C.D., Kennedy, B.J.: The malignant lymphomas. In: T.F. Nealon (ed.), Management of the patient with cancer, p. 917. Philadelphia-London-Toronto: W.B. Saunders Comp. 1976.Google Scholar
  167. Bloomfield, C.D., Kersey, J.H., Brunning, R.D., et al.: Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin’s lymphoma. Cancer Treat. Rep. 61, 963–970 (1977).PubMedGoogle Scholar
  168. Bloomfield, C.D., McKenna, R.W., Brunning, R.D.: Significance of haematological parameters in the non-Hodgkin’s malignant lymphomas. Brit. J. Haemat. 32, 41–46 (1976).PubMedGoogle Scholar
  169. Blum, R.H., Carter, S.K.: Adriamycin. — A new anti-cancer drug with significant clinical activity. Ann. intern. Med. 80, 299 (1974).Google Scholar
  170. Blum, R.H., Carter, S.K., Agre, K.: A clinical review of bleomycin — a new antineoplastic agent. Cancer 31, 903 (1973).PubMedGoogle Scholar
  171. Blumenberg, R.M., Olson, K.B., Stein, A.A., Hawkins, T.L.: Giant follicular lymphoma. Review of forty-six cases with special emphasis on prognosis. Amer. J. Med. 35, 832 (1963).PubMedGoogle Scholar
  172. Bockman, D.E., Wu, L. Y.F., Lawton, A.R., Cooper, M.D.: Altered fine structure of B lymphocytes correlated with defective terminal differentiation. Amer. J. Anat. 140, 551–568 (1974).PubMedGoogle Scholar
  173. Bodel, P.T., Nichols, B.A., Bainton, D.F.: Appearance of peroxidase reactivity within the rough endoplasmic reticulum of blood monocytes after surface adherence. J. exp. Med. 145, 264 (1977).PubMedGoogle Scholar
  174. Bodel, P.T., Nichols, B.A., Bainton, D.F.: Differences in peroxidase localization of rabbit peritoneal macrophages after surface adherence. Amer. J. Path. 91, 107 (1978).PubMedGoogle Scholar
  175. Bodey, G.P., Hersh, E.M.: Infection in children with malignant disease. In: Neoplasia in childhood, p. 135. Chicago: Yearbook 1969.Google Scholar
  176. Bodey, G.P., Rodriguez, V.: Prevention and treatment of infections in cancer patients. In: Clark, R.L., Cumley, R.W., McCay, J.E. (eds.), Oncology 1970, p. 456. Chicago: Yearbook 1971.Google Scholar
  177. Bodmer, W.F., Bodmer, J.G., Cullen, P.R., et al.: Ia antigens on chronic lymphocytic leukemic lymphocytes? Association between the reactions of VI Workshop sera on CLL and lymphoid cells. Histocompatibility Zesting, p. 685. Copenhagen: Munksgaard 1975.Google Scholar
  178. BÖhmer, E., Heite, H.J.: Über die Krankheitsdauer bei Mycosis fungoides. Arch. Derm. Syph. (Berl.) 196, 1–21 (1953 a).Google Scholar
  179. BÖhmer, E., Heite, H.J.: Über den Einfluß der Strahlentherapie auf die Lebensdauer von Mycosis-fungoides-Kranken. Strahlentherapie 92, 203–211 (1953 b).PubMedGoogle Scholar
  180. Boggs, D.R.: The cellular composition of inflammatory exudates in human leukemias. Blood 15, 466 (1960).PubMedGoogle Scholar
  181. Boiron, M., Flandrin, G., Ripault, J., Lortholary, P., Teillet, F., Jacquillat, C., Bernard, J.: Histo-lymphocytose médullaire et splenique d’apparence primitive. Nouv. Rev. franç. Hémat. 8, 179 (1968).PubMedGoogle Scholar
  182. Boldt, D.H., Speckart, S.F., MacDermatt, R.P., Nash, G.S., Valeski, J.E.: Leukemic reticuloen-dotheliosis: “hairy cell leukemia”, functional and structural features of the abnormal cell in a patient with profound leukocytosis. Blood 49, 745–757 (1977).PubMedGoogle Scholar
  183. Bom-van Noorloos, A.A., Splinter, T.A.W., van Heerde, P., et al.: Surface markers and functional properties of non-Hodgkin’s lymphoma cells in relation to histology. Cancer 42, 1804–1817 (1978).PubMedGoogle Scholar
  184. Bonadonna, C., Cheappa, R., Musumeci, R., Uslenghi, C.: Endolymphatic radiotherapy in malignant lymphomas. A clinical evaluation of 285 patients. Cancer 22, 885 (1968).PubMedGoogle Scholar
  185. Bonadonna, G.: Present position of radical and palliative treatment of malignant lymphomas, in: Chiappa, R., Musumeci, R., Uslenghi, C. (eds.), Endolymphatic radiotherapy in malignant lymphomas, pp. 1–22. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  186. Bonadonna, G., Banfi, A., Carnevali, G., et al.: Sedi preferenziali e madolita di diffusione dei linfomi maligni in base alio studio di 500 casi. Tumori 53, 551 (1967).PubMedGoogle Scholar
  187. Bonadonna, G., Beretta, G., Castellani, R., Canetta, R., Spinelli, P., Gennari, L., Rilke, F., Veronesi, U.: Current views on surgical staging in planning the treatment of malignant lymphomas. In: Recent advances in cancer treatment. New York: Raven Press 1977.Google Scholar
  188. Bonadonna, G., et al.: Clinical trials with bleomycin in lymphomas and in solid tumors. Europ. Cancer 8, 205–215 (1972).Google Scholar
  189. Bonadonna, G., Lattuada, A., Banfi, A.: Recent trends in the treatment of non Hodgkin’s lymphomas. Eur. J. Cancer 12, 661–673 (1976).PubMedGoogle Scholar
  190. Bonadonna, G., Lena, M. De, Lattuada, A., Milani, F., Monfardini, S., Beretta, G.: Combination chemotherapy and radiotherapy in non-hodgkin’s lymphomata. Brit. J. Cancer 31, Suppl. II, 481 (1975a).Google Scholar
  191. Bonadonna, G., Lena, M. De, Monfadini, S., Beretta, G., Valagussa, P.: Combination chemotherapy with adriamycin in malignant lymphomas. EORTC Internat. Sympos. Adriamycin Review, Brussels, May 1974, p. 200.Google Scholar
  192. Bonadonna, G., Lena, M. De, Monfardini, S., Beretta, G., Valagussa, P.: Combination chemotherapy with adriamycin in malignant lymphomas. In: EORTC Internat. Sympos. Adriamycin Review, p. 200. Ghent, Belgium: European Press Medikon 1975bGoogle Scholar
  193. Bonadonna, G., Monfardini, S.: Chemotherapy of non-Hodgkin’s lymphomas. Cancer Treat. Rev. 1, 167 (1974).Google Scholar
  194. Bonadonna, G., Pizzetti, F., Musumeci, R., Valagussa, P., Banfi, A., Veronesi, U.: Staging laparotomy in non-Hodgkin’s lymphomata. Brit. J. Cancer, Suppl. II, 31, 252 (1975).Google Scholar
  195. Bonadonna, G., Castellani, R., Narduzzi, C., Spinelli, P., Rilke, F.: Pathological staging in adult previously untreated non-Hodgkin’s lymphomas. Recent Results Cancer Res. 65, 41–50 (1978)PubMedGoogle Scholar
  196. Borja, E.R., Pugh, R.P.: Single-dose quinacrine (Atabrine) and thoracostomy in the control of pleural effusions in patients with neoplastic diseases. Cancer 31, 899–902 (1973).PubMedGoogle Scholar
  197. Bosman, F.T., Vloten, W.A. van: Sézary’s syndrome: a cytogenetic, cytophotometric and autoradiographic study. J. Path. 118, 49 (1976).PubMedGoogle Scholar
  198. Botterell, E.H., Fitzgerald, G.W.: Spinal cord compression produced by extradural malignant tumors: Early recognition, treatment and results. Canad. med. Ass. J. 80, 791–796 (1959).PubMedGoogle Scholar
  199. Bouillin, D.J., O’Brien, R.A.: Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down’s syndrome. J. Physiol. (Lond.) 212, 287–297 (1971).Google Scholar
  200. Bourgeois, J.-P. Le, Bridier, A., Bouhnik, H., Schlienger, M.: Whole cutaneous irradiation in mycosis fungoides with 55 KV X-rays. Bull. Cancer 64, 313–322 (1977).PubMedGoogle Scholar
  201. Bourlond, A., Smoes, J., Weert, J. De: Syndrom de Sézary. Arch, belges Derm. 26, 521 (1970).Google Scholar
  202. Bouroncle, B.A., Wiseman, B.K., Doan, C.A.: Leukemic reticuloendotheliosis. Blood 13, 609–630 (1958).PubMedGoogle Scholar
  203. Bouza, E., Burgaleta Golde, D.W.: Infections in hairy-cell leukemia. Blood 51, 851 (1978).PubMedGoogle Scholar
  204. Bowdler, A.J.: Blood volume studies in patients with splenomegaly. Transfusion 10, 171 (1970).PubMedGoogle Scholar
  205. Bower, G.C.: Chylothorax: Observations in 20 cases. Dis. Chest. 46, 46–468 (1964).Google Scholar
  206. Boyd, D.P.: Aggressive therapy for Hodgkin’s disease. Chest. 59, 357–358 (1971).PubMedGoogle Scholar
  207. Bragg, D.G.: The clinical, pathologic and radiographic spectrum of the intrathoracic lymphomas. Invest. Radiol. 13(1), 2–11 (1978).PubMedGoogle Scholar
  208. Branda, R.F.: Leukemic reticuloendotheliosis and “hairy cells”. New Engl. J. Med. 295, 1015 (1976).Google Scholar
  209. Brant-Zawadzki, M., Enzmann, D.R.: Computed tomographic brain scanning in patients with lymphoma. Radiology 129, 67–71 (1978).PubMedGoogle Scholar
  210. Braun, M., Sen, L., Bachman, A.E., et al.: Cell migration inhibition in human lymphomas using lymph node and cell line antigens. Blood 39, 368 (1972).PubMedGoogle Scholar
  211. Braun-Falco, O., Burg, G., Schmoeckel, Ch.: Klassifikation von malignen Hautlymphomen. Hautarzt 29, Suppl. III, 37–45 (1978).Google Scholar
  212. Braun-Falco, O., Burg, G., Wolff, H.H.: Kutane Lymphome und Pseudolymphome. Immunzytol. Enzymzytochem. und elektronenmikroskop. Untersuchungen. Ther. Umsch. 33, 543–550 (1976).Google Scholar
  213. Braun-Falco, O., Schmoeckel, Ch., Wolff, H.H.: The ultrastructure of mycosis fungoides, of Sézary’s syndrome, and of Woringer-Kolopp’s disease (pagetoid reticulosis). Bull. Cancer 64, 191–208 (1977).Google Scholar
  214. Braunstein, G.D., Vaitukaitis, J.L., Carbone, P.-P., Ross, G.T.: Ectopic production of human chorionic gonadotrophin by neoplasms. Ann. intern. Med. 78, 39–45 (1973)PubMedGoogle Scholar
  215. Braunsteiner, H., Schmalzl, F., Asamer, H.: Zytologische Untersuchungen bei „hairy cell“Leukämien. Acta med. austr. 1, 35 (1974).Google Scholar
  216. Braylan, R.C., Burke, J.S.: Hairy cell leukemia. Ann. Rev. Med. 30, 17–24 (1979).PubMedGoogle Scholar
  217. Braylan, R.C., Jaffe, E.S., Berard, C.W.: Malignant lymphomas. Current classification and new observations. Pathology Annual, Vol. 10, pp. 213–270. New York: Appleton-Century-Crofts 1965.Google Scholar
  218. Braylan, R.C., Jaffe, E.S., Berard, C.W.: Malignant lymphomas: Current classification and new observations, in Sommers, S.C. Pathology Annual, Vol. 10. New York: Appleton-Century-Crofts 1975.Google Scholar
  219. Braylan, R.C., Jaffe, E.S., Burbach, J.W., Frank, M.M., Johnson, R.E., Berard, C.W.: Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res. 36, 1619–1625 (1976).PubMedGoogle Scholar
  220. Braylan, R.C., Jaffe, E.S., Mann, R.B., Frank, M.M., Berard, C.W.: Surface receptors of human neoplastic lymphoreticular cells. In: Thierfelder, S., Rodt, H., Thiel, E., Immunological diagnosis of leukemias and lymphomas. Berlin — Heidelberg — New York: Springer 1977.Google Scholar
  221. Braylan, R.C., Jaffe, E.S., Triche, T.J., Nanba, K., Fowlkes, B.J., Metzger, H., Frank, M.M., Dolan, M.S., Yee, C.L., Green, I., Berard, C.W.: Structural and functional properties of the „hairy“cells of leukemic reticuloendotheliosis. Cancer 41, 210 (1978).PubMedGoogle Scholar
  222. Braylan, R.C., Long, J.C., Jaffe, E.S., et al.: Malignant lymphoma obscured by concomitant extensive epithelioid granulomas. Report of three cases with similar clinicopathologic features. Cancer (Philad.) 39, 1146–1155 (1977).Google Scholar
  223. Braylan, R.C., Sanders, S.K., Fowlkes, B.J., et al.: Cell size distribution, DNA content and thymidine incorporation in hairy cell leukemia. Proc. Amer Soc. Hemat. 123 a (1976).Google Scholar
  224. Braylan, R., Variakojis, D., Yachnin, S.: The Sézary syndrome lymphoid cell: abnormal mitogenic responsiveness and surface properties. Clin. Res. 21, 870 (1973).Google Scholar
  225. Braylan, R., Variakojis, D., Yachnin, S.: The Sézary syndrome lymphoid cell: Abnormal mitogenic responsiveness and surface properties. Brit. J. Haemat. 31, 553–564 (1975).PubMedGoogle Scholar
  226. Brearley, R.L., Chapman, R.M., Brozovic, B.: Hairy-cell leukemia presenting as aplastic anemia. Ann. intern. Med. 91, 228 (1979).Google Scholar
  227. Brecher, G., Haley, J.E., Wallenstein, R.O.: Nomenclature of red cells shape. Nouv. Rev. franc., Hémat. 12, 747 (1972).Google Scholar
  228. Brecher, M., Freeman, A., Panahon, A.: Childhood non-Hodgkin’s lymphoma. Proc. Amer. Ass. Cancer Res. and ASCO 17, 255 (1976).Google Scholar
  229. Brehmer-Andersson, E.: Mycosis fungoides and its relation to Sézary’s syndrome, lymphatoid papulosis and primary cutaneous Hodgkin’s disease. Acta derm.-venereol. (Stockh.) 56/Suppl. 75 (1976).Google Scholar
  230. Breiman, R.S., Castellino, R.A., Harell, G.S., et al.: CT-pathologic correlations in Hodgkin’s disease and non-Hodgkin’s lymphoma. Radiology 126, 159–166 (1978).PubMedGoogle Scholar
  231. Bremer, K.: Maligne Nicht-Hodgkin-Lymphome: Neue Aspekte zur Pathologie und Klinik. Diagnostik 10, 131–135 (1977).Google Scholar
  232. Brendis, L.M., Clarke, M.B., Williams, R.: Effect of splenectomy on the haemodilutional anaemia of splenomegaly. Lancet 1969 I, 795.Google Scholar
  233. Brereton, H.D., Fairey, R.N., Johnson, R.E.: Successful chemotherapy of advanced non-Hodgkin’s lymphoma after relapse following total body irradiation. Int. J. Radiât. Oncol. Biol. Phys. 2, 249 (1977).PubMedGoogle Scholar
  234. Brereton, H.D., Longo, D.L., Kirkland, L.R., et al.: A randomized prospective trial comparing chemotherapy (CRX) with total body irradiation (TBI) plus CRX in non-Hodgkin’s lymphomas. Proc. Amer. Ass. Cancer Res. and ASCO 19, 327 Abstr. C-84 (1978).Google Scholar
  235. Brereton, H.D., Young, R.C., Longo, D.L., Kirkland, L.R., Berard, C.W., Jaffe, E.S., DeVita, V.T., Johnsson, R.E.: A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin’s lymphoma. Cancer 43, 2227–2231 (1979).PubMedGoogle Scholar
  236. Breton-Gorius, J., Guichard, J.: Ultrastructural localization of peroxidase activity in human platelets and megakaryocytes. Amer. J. Path. 66, 277 (1972).PubMedGoogle Scholar
  237. Breton-Gorius, J., Reyes, F.: Ultrastructure of human bone marrow cell maturation. Int. Rev. Cytol. 46, 251 (1976).PubMedGoogle Scholar
  238. Breton-Gorius, J., Reyes, F., Duhamel, F., Najman, A., Gorin, N.C.: Megakaryoblastic acute leukemia. Identification by the ultrastructural demonstration of platelet-peroxidase. Blood 51, 45 (1978).PubMedGoogle Scholar
  239. Brewin, T.B.: Alcohol intolerance in neoplastic disease. Brit. med. J. 2, 437–441 (1966).PubMedGoogle Scholar
  240. Brewin, T.B.: Alcohol shift and alcohol dysphagia in Hodgkin’s disease, carcinoma of cervix, and other neoplasms. Brit. J. Cancer 20, 688–702 (1966).PubMedGoogle Scholar
  241. Brewin, T.B.: The incidence of alcohol intolerance in women with tumours of the uterus, ovary, or breast. Proc. roy. Soc. Med. 60, 1308–1309 (1967).PubMedGoogle Scholar
  242. Brier, A.M., Chess, L., Schlossman, S.F.: Human antibody-dependent cellular cytotoxicity. Isolation and indentification of a subpopulation of peripheral blood lymphocytes which koll antibody-coated autologous target cells. J. clin. Invest. 56, 1580–1586 (1975).PubMedGoogle Scholar
  243. Brittinger, G., Bartels, H., Bremer, K., et al.: Retrospektive Untersuchungen zur klinischen Bedeutung der Kiel Klassifikation der malignen Non Hodgkin Lymphome. Strahlentherapie 153, 222–228 (1977).PubMedGoogle Scholar
  244. Broder, S., Edelson, R.L., Lutzner, M.A., Nelson, D.L., MacDermott, R.P., Durm, M.E., Goldman, C.K., Meade, B.D., Waldmann, Th.A.: The Sézary syndrome. A malignant proliferation of helper T cells. J. clin.Invest. 58, 1297–1306 (1976).PubMedGoogle Scholar
  245. Broder, S., Uchiyama, T., Waldmann, Th.A.: Current concepts in immunoregulatory T-cell neoplasms. Cancer Treat. Rep. 63, 607–612 (1979).PubMedGoogle Scholar
  246. Brody, J.I., Burningham, R.A., Nowell, P.G., Rowlands, D.T., Jr., Freiburg, P., Daniele, R.P.: Persistent lymphocytosis with chromosomal evidence of malignancy. Amer. J. Med. 58, 547–552 (1975).PubMedGoogle Scholar
  247. Brody, J.I., Cypress, E., Kimball, S.G., McKenzie, D.: The Sézary syndrome. Arch, intern. Med. 110, 205–210 (1962).Google Scholar
  248. Broome, J.D., Zucker-Franklin, D., Weiner, M.S., et al.: Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sezary’s syndrome. Morphologic and immunologic studies. Clin. Immunol. Immunopath. 1, 319–329 (1973).Google Scholar
  249. Brouet, J.C., Clauvel, J.P., Danon, F., Klein, M., Seligmann, M.: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Amer. J. Med. 57, 775–788 (1974).PubMedGoogle Scholar
  250. Brouet, J.C., Flandrin, C.: Clinical and hematological heterogeneity of T-cell derived lymphoproli-ferative diseases. Bull. Cancer 64, 267–274 (1977).PubMedGoogle Scholar
  251. Brouet, J.C., Flandrin, G., Seligmann, M.: Indications of the thymus-derived nature of the proliferating cells in 6 patients with Sezary’s syndrome, New Engl. J. Med. 289, 341–344 (1973).Google Scholar
  252. Brouet, J.C., Labaume, S., Seligmann, M.: Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Brit. J. Cancer 31 (Suppl. II), 121 (1975).Google Scholar
  253. Brouet, J.C., Preud’Homme, J.L., Flandrin, G., Chelloul, N., Seligmann, M.: Brief communication: Membrane markers in „histiocytic“lymphomas (reticulum cell sarcomas). J. nat. Cancer Inst. 56, 631–633 (1976).PubMedGoogle Scholar
  254. Brouet, J.C., Seligmann, M.: Chronic lymphocytic leukaemia as an immunoproliferative discorder. Clin. Haemat. 6, 169 (1977).PubMedGoogle Scholar
  255. Brown, D.H., Swartzendruber, D.C., Carlton, J.E., Byrd, B.L., Hayes, R.L.: The isolation and characterization of Gallium-binding granules from soft tissue tumors. Cancer Res. 15, 185 (1976).Google Scholar
  256. Brown, R.S., Haynes, H.A., Foley, H.T., et al.: Hodgkin’s disease: immunologic, clinical, and histologic features of 50 untreated patients. Ann. intern. Med. 67, 291–302 (1967).PubMedGoogle Scholar
  257. Brown, T.C., Peters, M.V., Bergsagel, D.E., Reid, J.: A retrospective analysis of clinical results in relation to the Rappaport histological classification. Brit. J. Cancer 31, Suppl. II, 1974 (1975).Google Scholar
  258. Brownlee, T.R., Murad, T.M.: Ultrastructure of mycosis fungoides. Cancer 26, 686 (1970).PubMedGoogle Scholar
  259. Brubaker, D.B., et al.: Correlations of immunologic markers with histologic features of human non-Hodgkin’s lymphomas. Amer. J. clin. Path. 71, 651–664 (1979).Google Scholar
  260. Brugère, J., et al.: Lymphosarcomes et réticulosarcomes des voies aéro-digestives supérieures. Bull. Cancer 61, 79–92(1974).PubMedGoogle Scholar
  261. Brugère, J., Dumont, J., Jaulerry, C., Schwaab, G.: Invasion of the upper respiratory and digestive tract in adult lymphoid neoplasias. Results Cancer Res. 65, 59–62 (1978).Google Scholar
  262. Brugère, J., Schlienger, M., Gérard-Marchant, B., Tubiana, M., Pouillart, P., Cachin, Y.: Non-Hodgkin’s malignant lymphmata of upper digestive and respiratory tract: Natural history and results of radiotherapy. Brit. J. Cancer 31, Supp. II, 435–440 (1975).Google Scholar
  263. Bruneau, R., Rubin, P.: The management of pleural effusions and chylothorax in lymphoma. Radiology 85, 1085–1092 (1965).PubMedGoogle Scholar
  264. Brunk, S.F., Gulesserian, H.P., Hass, A.C., et al.: Exploratory laparotomy and splenectomy in staging lymphomas. Clin. Res. 18, 470 (1970).Google Scholar
  265. Brunner, K.W., Young, C.W.: A methylhydrazine derivative in Hodgkin’s disease and other malignant neoplasms. Ann. intern. Med. 63, 69 (1965).PubMedGoogle Scholar
  266. Brunning, R.D., Bloomfield, C.D., McKenna, R.W., et al.: Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic disorders. Ann. intern. Med. 82, 365 (1975).PubMedGoogle Scholar
  267. Brunning, R.D., Parkin, B.S.: Ribosome-lamella complexes in neoplastic hematopoietic cells. Amer. J. Path. 79, 565–572 (1975).PubMedGoogle Scholar
  268. Brunning, R.O., Parkin, J.: Intranuclear inclusions in plasma cells and lymphocytes from patients with monoclonal gammopathies. Amer. J. clin. Path. 66, 10–21 (1976).Google Scholar
  269. Brunt, P.W., Sircus, W., Maclean, N.: Neoplasia and the coeliac syndrome in adults. Lancet 1969 I, 180–184.Google Scholar
  270. Buchanan, J.G., Gruchy, G.C. De: Med. J. Aust. II, 6 (1967).Google Scholar
  271. Buchner, L.J., Scheierson, S.S.: Clinical and laboratory aspects of Listeria Monocytogenes infections. Amer. J. Med. 45, 904 (1968).PubMedGoogle Scholar
  272. Buckingham, J.C., McClure, J.H.: Reticulum cell sarcoma of vulva: Report of case. Obstet. Gynec. 6, 138–143 (1955).PubMedGoogle Scholar
  273. Büchner, S., Rufli, T.: Manifestation eines malignen Lymphoms von hohem Malignitätsgrad im Spätstadium der Mycosis Fungoides. Dermatologica (Basel) 159, 125–131 (1979).Google Scholar
  274. Büchner, S.A.: Enzymzytochemische und immunzytologische Differenzierung von Infiltratzellen in der Haut bei Mycosis fungoides. Dermatologica (Basel) 159, 386–392 (1979).Google Scholar
  275. Büchner, S.A., Rufli, Th.: Enzymzytochemische Untersuchungen kutaner maligner Lymphome mittels einfacher Abstrichpräparate. Hautarzt 29, 323–327 (1978).PubMedGoogle Scholar
  276. Buell, D., Norman, J.: APO: Adriamycin-based Regimen for childhood Non-Hodgkins lymphoma. AACR (Toronto) 1976Google Scholar
  277. Bull, J.M., DeVita, V.T., Carbone, P.P.: In vitro granulocyte production in patients with Hodgkin’s disease and lymphocytic, histiocytic, and mixed lymphomas. Blood 45, 833–842 (1975).PubMedGoogle Scholar
  278. Bunn, P.A., Schein, P.S.: Meningeal involvement in lymphoma. New Engl. J. Med. 290, 517 (1974).PubMedGoogle Scholar
  279. Bunn, P.A., Schein, P.S., Banks, P.M., DeVita, V.T.: Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: Leukemia revisted. Blood 47, 3–10 (1976).PubMedGoogle Scholar
  280. Burchardt, K., Kelly, G.E., Slezak, P., et al.: A case of lymphoma with T cell characteristics. Aust. N.Z. J. Med. 5, 158–161 (1975).PubMedGoogle Scholar
  281. Burg, C.: Fortschritte in der Diagnostik kutaner Lymphome. Fortschr. Med. 94, 1089–1098 (1976).PubMedGoogle Scholar
  282. Burg, G., Braun-Falco, O.: Qualitative und quantitative Aspekte der cellulären Reaktion in Haut und Blut bei Mycosis fungoides. Hautarzt 25, 178–187 (1974 a).PubMedGoogle Scholar
  283. Burg, G., Braun-Faclo, O.: Fortschritte der cytochemischen Differenzierung von Infiltratzellen in der Haut. Hautarzt 25, 1–8 (1974b).PubMedGoogle Scholar
  284. Burg, G., Braun-Falco, O.: T- und B-Lymphozyten in Hautveränderungen kutaner Lymphome. Ein Beitrag zur Klassifikation lymphoretikulärer Proliferationen in der Haut. Dtsch. med. Wschr. 100, 2562–2564 (1975 a).PubMedGoogle Scholar
  285. Burg, G., Braun-Falco, O.: Classification and differentiation of cutaneous lymphomas, Enzymecytochemical and immunocytological studies. Brit. J. Derm. 93, 597–599 (1975b).PubMedGoogle Scholar
  286. Burg, G., Braun-Falco, O.: Morphologica and functional differentiation and classification of cutaneous lymphomas. Bull. Cancer 64, 225–240 (1977).PubMedGoogle Scholar
  287. Burg, G., Braun-Falco, O.: Cutaneous non-Hodgkin lymphoma: Re-evaluation of histology using enzymecytochemical and immunologic studies. Int. J. Derm. 17, 496–505 (1978 a).PubMedGoogle Scholar
  288. Burg, G., Braun-Falco, O.: Methoden zur Klassifikation der Hautlymphome. Hautarzt 29, Suppl. III, 5–13 (1978b).Google Scholar
  289. Burg, G., Braun-Falco, O., Hoffmann-Fezer, G., Rodt, H., Schmoeckel, Ch.: Patterns of cutaneous lymphomas. Histol. enz. cytoch. and immun, typing of lymphoret. proliferations in the skin. Dermatologica (Basel) 157, 282–291 (1978b).Google Scholar
  290. Burg, G., Braun-Falco, O., Schmoeckel, Ch.: Kutane T-Zell-Lymphome. Fortschr. Med. 96, 199–205 (1978 a).PubMedGoogle Scholar
  291. Burg, G., Rodt, H., Grosse-Wilde, H., Braun-Falco, O.: Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary syndrome. J. invest. Derm. 70, 257–259 (1978 c).PubMedGoogle Scholar
  292. Burgaleta, C., Golde, D.W.: Leucosis de celulas peludas: Una neoplasia de linfocitos B. Sangre (Barcelona) 22, 148–158(1977).Google Scholar
  293. Burke, J.F., Jr., Flis, R., Lasker, N., Simenhoff, M.: Malignant lymphoma with „myeloma kidney“acute renal failure. Amer. J. Med. 60, 1055–1060 (1976).PubMedGoogle Scholar
  294. Burke, J.S.: The value of the bone-marrow biopsy in the diagnosis of hairy cell leukemia. Amer. J. clin. Path. 70, 876–884(1978).Google Scholar
  295. Burke, J.S., Byrne, G.E., Jr., Rappaport, H.: Hairy cell leukemia (leukemic reticuloendotheliosis). I. A clinical pathologic study of 21 patients. Cancer 33, 1399–1410 (1974).PubMedGoogle Scholar
  296. Burke, J.S., Mackay, B., Rappaport, H.: Hairy cell leukemia (leukemic reticuloendotheliosis). II. Ultrastructure of the spleen. Cancer 37, 2267–2274 (1976).PubMedGoogle Scholar
  297. Burke, M.D., Melamed, M.R.: Exfoliative cytology of metastatic cancer in lung. Acta cytol. (Philad.) 12, 61–74(1968).Google Scholar
  298. Burkhardt, R.: Präparative Voraussetzungen zur klinischen Histologie des menschlichen Knochenmarks. I. Methodische Untersuchungen zur Acrylateinbettung größerer lipidreicher Gewebsproben. Blut 13, 1 (1966).Google Scholar
  299. Burkhardt, R.: Farbatlas der klinischen Histopathologic von Knochenmark und Knochen. Berlin-Heidelberg-New York: Springer 1970.Google Scholar
  300. Burman, S.O., Wyk, F.A. van: Lymphomas of the small intestine and cecum. Ann. Surg. 143, 349–359 (1956).PubMedGoogle Scholar
  301. Burnet, M.: Cancer. — A biological approach. Brit. med. J. 1, 779 (1957).PubMedGoogle Scholar
  302. Burns, C.P.: Serum-muramidase in leukaemic reticuloendotheliosis. Lancet 1974 II, 964.Google Scholar
  303. Burns, C.P., Maca, R.D., Hodk, J.C.: Biochemical, morphological and immunological observations of leukemic reticuloendotheliosis. Cancer Res. 33, 1615 (1973).PubMedGoogle Scholar
  304. Burns, E.R., Soloff, B.L., Hanna, C., Buxton, D.F.: Nuclear pockets associated with the nucleolus in normal and neoplastic cells. Cancer Res. 31, 158–165 (1971).Google Scholar
  305. Burns, G.F., Baker, C.R., Cawley, J.C., Hayhoe, F.G.J.: The rate of membrane turnover by the hairy cells of leukemic reticuloendotheliosis: A kinetic study of a receptor for IgM: J. Immunol. 119, 1279–1284 (1977 a).PubMedGoogle Scholar
  306. Burns, G.F., Cawley, J.C.: A re-examination of the alleged monocytic features of hairy-cell leukaemia. Scand. J. Haemat. 22, 386 (1979).PubMedGoogle Scholar
  307. Burns, G.F., Cawley, J.C., Barker, C.R., Goldstone, A.H., Hayhoe, F.G.J.: New evidence relating to the nature and origin of the hairy cell of leukaemic reticuloendotheliosis. Brit. J. Hemat. 36, 71 (1977b).Google Scholar
  308. Burns, G.F., Cawley, J.C., Barker, C.R., Hayhoe, F.G.J.: Absence of a receptor for fixed C3 on the hairy cells of leukaemic reticuloendotheliosis. Clin. exp. Immunol. 29, 442–446 (1977 c).PubMedGoogle Scholar
  309. Burns, G.F., Flemans, R.J., Barker, C.R., Cawley, J.C., Worman, C.P., Hayhoe, F.G.J.: Leukemic reticuloendotheliosis and „hairy cells“. New Engl. J. Med. 295, 1015 (1976).Google Scholar
  310. Burns, G.F., Nash, A.A., Worman, C.P., et al.: A human leukaemic cell expressing hybrid membrane phenotypes. Nature (Lond.) 268, 243–245 (1977d).Google Scholar
  311. Burns, G.F., Cawley, J.C., Higgy, K.E., Barker, C.R., Edwards, M., Rees, J.K.H., Hayhoe, F.G.J.: Hairy-cell leukaemia: a B-cell neoplasm with a severe deficiency of normal B lymphocytes. Leukemia Res. 2, 33–40 (1978).Google Scholar
  312. Burns, G.F., Cawley, J.C., Higgy, K.E., Barker, C.R., Edwards, M., Rees, J.K., Hayhoe, F.G.: Hairy-cell leukaemia: a B-cell neoplasm with a severe deficiency of normal B-lymphocytes. Blood 52, 33–40 (1978)Google Scholar
  313. Burns, G.F., Cawley, J.C., Worman, C.P., Barker, C.R., Hayhoe, F.G.J.: Hairy-cell leukaemia. Brit. med. J. 1, 1278 (1978)PubMedGoogle Scholar
  314. Burns, G.F., Cawley, J.C., Worman, C.P., Karpas, A., Barker, CR., Goldstone, A.H., Hayhoe, F.G.J.: Multiple heavy chain isotypes on the surface of the cells of hairy cell leukemia. Blood 52, 1132(1978).PubMedGoogle Scholar
  315. Burstein, S.D., Kernohan, J.W., Uchlein, A.: Neoplasms of the reticuloendothelial system of the brain. Cancer 16, 289–305 (1963).PubMedGoogle Scholar
  316. Bush, R.S., Ash, C.L.: Primary lymphoma of the gastrointestinal tract. Radiology 92, 1349–1354 (1969).PubMedGoogle Scholar
  317. Bush, R.S., Gospodarowicz, M., Sturgeon, J., Alison, R.: Radiation therapy of localized non-Hodgkin’s lymphoma. Cancer Treatm. Rep. 61, 1129–1136 (1977).Google Scholar
  318. Buskard, N.A., Catovsky, A., Okos, J.M., Goldman, D.A.G.: Prolymphocytic leukemia: cell studies and treatment by leucapheresis. In: Löffler, H. (ed.), Maligne lymphome und monoclonale gammopathien. München: Lehmann 1976.Google Scholar
  319. Butler, J.J., Stryker, J.A., Shullenberger, C.C.: A clinicopathological study of stages I and II. Non-Hodgkin’s lymphomata using the Lukes-Collins classification. Brit. J. Cancer 31, Suppl. II, 208–216 (1975).Google Scholar
  320. Buzdar, U., Gamble, J.F., Martin, R.G., Shullenberger, C.C.: Results of staging laparotomy in lymphogram staged I and II non-Hodgkin’s lymphoma. ASCO Abstr. 1976, p. 257.Google Scholar
  321. Byrne, G.E., Jr.: Rappaport classification of non-Hodgkin’s lymphoma: histologic features and clinical significance. Cancer Treat. Rep. 61, 935–944 (1977).PubMedGoogle Scholar
  322. Cabanillas, F., Burke, J.J.: Prognostic factors in adults with advanced Non-Hodgkin’s Lymphoma (NHL). ASCO Abstr. 1976, p. 256.Google Scholar
  323. Cabanillas, F., Zornoza, J., Haynie, T.P., Rodriguez, V.: Comparison of lymphangiograms and gallium scans in the non Hodgkin’s lymphomas. Cancer 39 (1), 85–88 (1977).PubMedGoogle Scholar
  324. Cabanillas, F., Rodriguez, V., Hersh, E.M., Mavligit, G., Bodey, G.P., Middleman, E.L.: Chemoimmunotherapy of advanced Non-Hodgkin’s Lymphoma (NHL) with chop-bleo + levami-sole. Proc. Amer. Soc. Clin. Onkol. 1977, p. 328.Google Scholar
  325. Cabanillas, F., Smith, T., Bodey, G.P., Gutterman, J.U., Freireich, E.J.: Nodular malignant lymphomas factors affecting complete response rate and survival. Cancer 44, 1983–1989 (1979).PubMedGoogle Scholar
  326. Cabré Fiol V., Vilardell F.: Progress in the cytological diagnosis of gastric lymphoma. Cancer 41, 1456–1461 (1978).Google Scholar
  327. Cadeau, B.J., Blackstein, M.E., Malkin, A.: Increased incidence of placenta-like alkyline phosphatase activity in breast and genitourinary cancer. Cancer Res. 34, 729 (1974).PubMedGoogle Scholar
  328. Cadman, E., Färber, L., Berd, D., Bertino, J.: Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites. Cancer Treat. Rep. 61, 1109–1116 (1977).PubMedGoogle Scholar
  329. Caires, G. de, Gagnon, J.H.: Lymphography in clinically suspected lymphoma: retrospective analysis of 63 cases. Radiology 121, 631–634 (1976).PubMedGoogle Scholar
  330. Calabro, J.J.: Cancer and arthritis. Arthritis Rheum. 10, 553 (1967).PubMedGoogle Scholar
  331. Caldwell, J.R., Ruddy, S., Schur, P.H., Austen, K.F.: Acquired Cl-inhibitor deficiency in lymphosarcoma. Clin. Immunol. Immunopath. 1, 39–52 (1972).Google Scholar
  332. Campos, M.E., Rabinovich, S., Smith, I.M.: The nitroblue tetrazolium test. An evaluation of the false-positive and false-negative results. (Zusammenfassung.) Arch, intern. Med. 113, 432 (1974).Google Scholar
  333. Canellos, G.P., Lister, T.A.: Annotation. The staging and treatment of non-Hodgkin’s lymphoma. Brit. J. Haemat. 39, 477–482 (1978).PubMedGoogle Scholar
  334. Canellos, G.P., DeVita, V.T., Young, R.C., Chabner, B.A., Schein, P.S., Johnson, R.E.: Therapy of advanced lymphocytic Lymphoma A preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Brit. J. Cancer 31, Suppl. II, 474–480 (1975).Google Scholar
  335. Cantor, R.E., Cohn, E.M., Park, C.H., et al.: Comparative liver scanning’ Technetium sulfide Tc 99m vs gold Au 198. J. Amer. med. Ass. 211, 1677–1680 (1970).Google Scholar
  336. Cantrell, E.G.: Nephrotic syndrome cured by removal of gastric carcinoma. Brit. med. J. II, 739 (1969).Google Scholar
  337. Carabell, S.C., Cassady, J.R., Weinstein, H.J., Jaffe, N.: The role of radiation therapy in the treatment of pediatric non-Hodgkin’s lymphomas. Cancer 42, 2193 (1978).PubMedGoogle Scholar
  338. Carabell, S.C., Chaffey, J.T., Rosenthal, D.S., Moloney, W.C., Hellman, S.: Results of total body irradiation in the treatment of advanced non-Hodgkin’s lymphomas. Cancer 43, 994 (1979).PubMedGoogle Scholar
  339. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M.: Report of the Committee on Hodgkin’s disease. Staging classification. Cancer Res. 31, 1860–1861 (1971).PubMedGoogle Scholar
  340. Carbone, P.P., Spurr, C., Schneiderman, M., et al.: Management of patients with malignant lymphoma. A comparative study with cyclophosphamide and vinca alkaloids. Cancer Res. 28, 811 (1968).PubMedGoogle Scholar
  341. Carella, A.M., Bacigalupo, A., Santini, G., Giordano, D., Damasio, E.E., Fusco, F.A., Rossi, E., Marmont, A.M.: Peptichemio: a new oncolytic drug in combination with vincristine and prednisolone in the treatment of non-Hodgkin lymphomas. Acta haemat. (Basel) 57, 211–224 (1977).Google Scholar
  342. Carlin, R., Henderson, J.W.: Malignant lymphoma of the nasolacrimal sac. Amer. J. Ophthal. 78, 511–513(1974).Google Scholar
  343. Carter, R.L.: Infectious mononucleosis: model for self-limiting lymphoproliferation. Lancet 1975 I, 846.Google Scholar
  344. Carter, S.K.: An overview of the status of the nitrosureas in other tumors. Cancer Chemother. Rep., Part 3, 4, 35 (1973).Google Scholar
  345. Caruso, R.D., Berk, R.N.: Lymphoma of the esophagus. Radiology 95, 381–382 (1970).PubMedGoogle Scholar
  346. Casazza, A.R., Duvall, C.P., Carbone, P.P.: Infection in lymphoma. J. Amer. med. Ass. 197, 710 (1966).Google Scholar
  347. Casazza, A.R., Duvall, C.P., Carbone, P.P.: Summary of infectious complications occurring in patients with Hodgkin’s disease. Cancer Res. 26, 1290 (1966).PubMedGoogle Scholar
  348. Case Records: Case records of the Massachusetts General Hospital. New Engl. J. Med. 289, 91 (1973).Google Scholar
  349. Case Records: Case records of the Massachusetts General Hospital: Case 13 – 1975. New Engl. J. Med. 292, 689 (1975).Google Scholar
  350. Case Records: Case records of the Massachusetts General Hospital: Case 41 – 1976. New Engl. J. Med. 295, 828–834 (1976).Google Scholar
  351. Case Records: Case records of the Massachusetts General Hospital: Case 21 – 1977. New Engl. J. Med. 296, 1218 (1977).Google Scholar
  352. Casey, T.P.: The development of lymphomas in mice with autoimmune disorders treated with azathioprine. Blood 31, 396 (1968).PubMedGoogle Scholar
  353. Caspersson, T., Zech, L., Johansson, C., Modest, E.J.: Identification of human chromosomes by DNA-binding fluorescing agents. Chromosoma (Berl.) 30, 215–227 (1970).Google Scholar
  354. Castaneda Zuniga, W.R., Amplatz, K.: Angiography of the liver in lymphoma. Radiology 122, 679–681 (1977).Google Scholar
  355. Castellani, R., Bonadonna, G., Spinelli, P., Bajetta, E., Galante, E., Rilke, F.: Sequential pathologic staging of untreated non-Hodgkin’s lymphomas by laparoscopy and laparotomy combined with marrow biopsy. Cancer 40, 2322 (1977).PubMedGoogle Scholar
  356. Castellino, R., Filly, R., Blank, N.: Routine full-lung tomography in the initial staging and treatment planning of patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Cancer 38, 1130–1136(1976).PubMedGoogle Scholar
  357. Castellino, R.A., Billingham, M., Dorfman, R.A.: Lymphographic accuracy in Hodgkin’s disease and malignant lymphoma with a note on the „reactive“lymph node as a cause of most false-positive lymphograms. Invest. Radiol. 9, 155 (1974).PubMedGoogle Scholar
  358. Castellino, R.A., Goffinet, R., Blank, N., Parker, B.R., Kaplan, H.S.: The role of radiography in the staging of non-Hodgkin’s lymphoma with laparotomy correlation. Radiology 110, 329–338 (1974).PubMedGoogle Scholar
  359. Castleberry, R.P., Toben, H.R., Moreno, H.: An evaluation of malignant cell origin in lymphosarcoma of childhood. Blood 42, 1025 (1973).Google Scholar
  360. Castro-Malaspina, H., Najean, Y., Flandrin, G.: Erythrokinetic studies in hairy-cell leukaemia. Brit. J. Haemat. 42, 189 (1979).PubMedGoogle Scholar
  361. Cathcart, R.S., Sutton, J.P., Gregorie, H.B., Jr.: Sarcomas of the stomach. Ann. Surg. 173, 398–402 (1971).PubMedGoogle Scholar
  362. Catlin, D.: Lymphosarcoma of the head and neck. Amer. J. Roentgenol. 59, 354–358 (1948).Google Scholar
  363. Catlin, D.: Surgery for head and neck lymphomas. Surgery 60, 1160–1166 (1966).PubMedGoogle Scholar
  364. Catovsky, D.: Hairy cell leukemia and prolymphocytic leukemia. Clin. Hemat. 6, 245 (1977).Google Scholar
  365. Catovsky, D., Galton, D.A.G.: Lysozyme activity and nitroblue tetrazolium reduction in leukaemic cells. J. clin. Path. 26, 60–69 (1973).PubMedGoogle Scholar
  366. Catovsky, D., Holt, P.J.L., Dalton, D.A.G.: Lymphocyte transformation in immunoproliferative disorders. Brit. J. Cancer 26, 154–163 (1972).PubMedGoogle Scholar
  367. Catovsky, D., Pettit, J.E., Galetto, J., Okos, A., Galton, D.A.G.: The B-lymphocyte nature of the hairy cell of leukemic reticuloendotheliosis. Brit. J. Haemat. 26, 29–37 (1974b).PubMedGoogle Scholar
  368. Catovsky, D., Pettit, J.D., Galton, D.A.G., Spiers, A.S.D., Harrison, C.V.: Leukemic reticuloendotheliosis („hairy“cell leukemia): A distinct clinico-pathological entity. Brit. J. Haemat. 26, 9–27 (1974 c).PubMedGoogle Scholar
  369. Catovsky, D., Frisch, B., Okos, A., Noorden, S. Van: Scanning electron microscopy and the nature of the hairy cell. Lancet 1975 I, 462.Google Scholar
  370. Catovsky, D., Galetto, J., Okos, A., et al.: Cytochemical profile of B and T leukemic lymphocytes with special reference to acute lymphoblastic leukemia. J. clin. Path. 27, 767–771 (1974 a).PubMedGoogle Scholar
  371. Catovsky, D., Papamichail, M., Okos, A., Noorden, S. Van: Formation of mouse red cell rosettes by “hairy”cells. Biomedicine 23, 81–84 (1975).PubMedGoogle Scholar
  372. Catovsky, D., Cherichi, M., Okos, A., Heoge, U., Galton, D.A.G.: Mouse red-cell rosettes in B-lymphoproliferative disorders. Brit. J. Haemat. 33, 173–177 (1976).PubMedGoogle Scholar
  373. Catovsky, D., Sperandion, P., O’Brien, M., Cherichi, M., Galton, D.A.G.: Phagocytic potentialof leukaemic B lymphocytes. Scand. J. Haemat. 19, 211–216 (1977).PubMedGoogle Scholar
  374. Cawley, J.C., Burns, G.F., Bevan, A., Worman, C.P., Smith, J.L., Gray, L., Barker, C.R., Haljhoe, F.G.J.: Typical hairy-cell leukaemia with IgGk paraproteinaemia. Brit. J. Haemat. 43, 215(1979).PubMedGoogle Scholar
  375. Cawley, J.C., Burns, G.F., Nash, T.A., Higgy, K.E., Child, J.A., Roberts, B.E.: Hairy-cell leukemia with T-cell features. Blood 51, 61–69 (1978).PubMedGoogle Scholar
  376. Cawley, J.C., Emmines, J., Goldstone, A.H., Hamblin, J., Hough, D., Smith, J.: Distinctive cytoplasmic inclusions in chronic lymphocytic leukemia. Europ. J. Cancer 11, 91–93 (1975).Google Scholar
  377. Cazal, P.: La reticulose histiomonocytaire, 1 vol. Paris: Masson & Cie. 1946.Google Scholar
  378. Celle, R., Zajdela, A., Haye, C., Schlienger, P.: Primary malignant lymphoid tumors of the orbit. The eye and its adnexa. Eye, Ear, Nose, Thr. Monthly 54, 141–149 (1975).Google Scholar
  379. Chabner, B.A., Johnson, F.E., Chretien, P.B., et al.: Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomata. Brit. J. Cancer 31 (Suppl II), 242 (1975).Google Scholar
  380. Chabner, B.A., Johnson, R.E., DeVita, V.T., et al.: Sequential staging in non-Hodgkin’s lymphoma. Cancer Treat. Rep. 61, 993–997 (1977)PubMedGoogle Scholar
  381. Chabner, B.A., Johnson, R.E., Young, R.C., Canellos, G.P., Hubbard, S.P., Johnson, S.K., DeVita, V.T., Jr.: Sequential nonsurgical and surgical staging of non-Hodgkin’s lymphoma. Ann. Intern. Med. 85, 149–154 (1976) (Main article)PubMedGoogle Scholar
  382. Chabner, B.A., Johnson, R.E., Young, R.C., Canellos, G.P., Hubbard, S.P., Johnson, S.K., DeVita, V.T.: Sequential nonsurgical and surgical staging of non-Hodgkin’s lymphoma. Cancer 42, 922 (1978).PubMedGoogle Scholar
  383. Chabner, B.A., Johnson, R.E., Young, R.C., Canellos, G.P., Johnson, S.K., DeVita, V.T.: Importance of pre-laparotomy staging in Non-Hodgkin’s Lymphoma (NHL). ASCO Abstr. 1976 Toronto.Google Scholar
  384. Chaffey, J.T., Rosenthal, D.S., Moloney, W.C., et al.: Total body irradiation as treatment for lymphosarcoma. Int. J. Radiât. Oncol. Biol. Phys. 1, 399–405 (1976).PubMedGoogle Scholar
  385. Chaffey, J.T., Rosenthal, D.S., Pinkus, G., Hellman, S.: Advanced lymphosarcoma treated by total body irradiation. Brit. J. Cancer 31, Suppl II, 441–449 (1975).Google Scholar
  386. Chaffey, W.C.: Lymphosarcoma of the bladder (cord specimen). Trans, path. Soc. Lond. 36, 285 (1885).Google Scholar
  387. Chan, W.C., Griem, M.L., Grozea, P.N., Freel, R.J., Variakojis, D.: Mycosis fungoides and Hodgkin’s disease occurring in the same patient. Cancer 44, 1408–1413 (1979).PubMedGoogle Scholar
  388. Chang, J.C., Appleby, J., Bannet, J.M.: Nitroblue tetrazolium test in Hodgkin disease and other malignant lymphomas. (Zusammenfassung.) Arch, intern. Med. 133, 401 (1974).Google Scholar
  389. Chantar, C., Bootello, A., Anaya, A., et al.: Linfoma mediterraneo. Rev. clin. esp. 148, 215–221 (1978).Google Scholar
  390. Chaoul, H., Lange, K.: Über Lymphogranulomatose und ihre Behandlung mit Roentgenstrahlen. Münch. med. Wschr. 70, 725 (1923).Google Scholar
  391. Chapman, R.S., Paul, C.J.: Poikiloderma atrophicans vasculare as a pointer to reticulosis of the skin. Postgrad, med. J. 51, 463–467 (1975).Google Scholar
  392. Chaudhry, A.A., Yam, L.T.: Impaired hemopoietic function of bone marrow in Leukemic Reticuloendotheliosis (LRE). AACR Abstr. Toronto (1976).Google Scholar
  393. Chelloul, N., Daniel, M.T., Flandrin, G.: Histiolymphocytose de l’adulte ou leucémie a tricholeucocytes: Etude histologique, cytologique et ultrastructurale. Path, europ. 8, 235–251 (1973).Google Scholar
  394. Chen, K.T.K., Bloomfield, C.D., McKenna, R.W., Brunning, R.D.: Double bilateral bone marrow biopsies in staging patients with lymphoma. AACR Abstr. 18, 179 (1977).Google Scholar
  395. Chen, K.Y., Fletcher, G.H.: Malignant tumors of the nasopharynx. Radiology 99, 165–171 (1971).PubMedGoogle Scholar
  396. Chen, M., Prosnitz, L.R., Gonzalez-Serva, A., Fischer, D.B.: Results of radiotherapy in control of stage I and II non-Hodgkin’s lymphoma. Cancer 43, 1245–1254 (1979).PubMedGoogle Scholar
  397. Chervenick, P.A., LoBuglio, A.F.: Human blood monocytes: Stimulators of granulocytes and mononuclear colony formation in vitro. Science 178, 164–168 (1972).PubMedGoogle Scholar
  398. Chiao, J.W., Pantic, V.S., Good, R.A.: Human peripheral blood lymphocytes bearing both B-cell complement receptors and T-cell characteristics for sheep erythrocytes detected by a mixed rosette method. Clin. exp. Immunol. 18, 483 (1974).PubMedGoogle Scholar
  399. Chiappa, S., Musumeci, R., Usleghi, C.: Endolymphatic radiotherapy in malignant lymphomas. Recent results in cancer research N, 37. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  400. Child, J.A., Cawley, J.C., Martin, S., Ghoneim, A.T.M.: Microbicidal function of the neutrophils in hairy-cell leukaemia. Acta haemat. (Basel) 62, 191 (1979).Google Scholar
  401. Child, J.A., Martin, S., Cawley, J.C., Ghoneim, A.T.M.: Defective microbicidal function of neutrophils in haematological malignancies and lymphomas: correction by levamisole in vitro. Biomedicine 29, 159–161 (1978).PubMedGoogle Scholar
  402. Chioléro, J.: Un cas de lymphogranulomatose primitive de l’oesophage. Ann. Annat. pat. 12, 305–310 (1935).Google Scholar
  403. Christensen, B.E.: Effect of an enlarged splenic erythrocyte pool in chronic lymphocytic leukaemia. Mechanism of erythrocyte sequestration in the spleen and liver. Scand. J. Haemat. 8, 92 (1971).Google Scholar
  404. Chu, A.C., MacDonald, D.M.: Identification in situ of lymphocytes in the dermal and epidermal infiltrates of mycosis fungoides. Brit. J. Derm. 100, 177–182 (1979).PubMedGoogle Scholar
  405. Churchill, E.D.: Malignant lymphoma of lung and pulmonary coccidiomycosis: Clinic on surgical lesions of lung with consolidation. Surg. Clin. N. Amer. 27, 1113–1120 (1947).PubMedGoogle Scholar
  406. Cihak, R.W., Hamada, J.: Primary reticulum cell sarcoma of the uterus. Cancer (N.Y.) 33, 1039–1044 (1974).Google Scholar
  407. Civatte, J.: Histopathologic cutanée. Paris: Editions Médicales Flammarion 1967.Google Scholar
  408. Civatte, J., Kapetis, E.: Problems in histological diagnosis of mycosis fungoides. Bull. Cancer 64, 187–190 (1977).PubMedGoogle Scholar
  409. Clagett, O.T., Allen, T.H., Payne, W.S., et al.: The surgical treatment of pulmonary neoplasms: A 10-year experience. J. Thorac. cardiovasc. Surg. 48, 391–400 (1964).PubMedGoogle Scholar
  410. Clarkson, B., Krakoff, I., Burchenal, J., Karnofsky, D., Golbey, R., Dowling, M., Oettgen, H., Lipton, A.: Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma and solid tumors. Cancer 25, 279 (1970).PubMedGoogle Scholar
  411. Claudy, A.L., Schmitt, D., Alario, A., Brochier, J., Perrot, H., Thivolet, J.: Immunocytological characterization of the mycosis fungoides tumour cell. Bull. Cancer 64, 241–248 (1977).PubMedGoogle Scholar
  412. Claudy, A.L., Schmitt, D., Viac, J., Alario, A., Staquet, M.J., Thivolet, J.: Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin. exp. Immunol. 23, 61–68 (1976).PubMedGoogle Scholar
  413. Clausen, R.E., Lincoln, A.F., Silberman, H.K.: Diffuse lymphosarcomatosis of the central nervous system simulating infectious polyneuritis. Amer. J. Med. 20, 292–300 (1956).PubMedGoogle Scholar
  414. Clendenning, W.E.: Mycosis fungoides. History, clinical features, controversies. Bull. Cancer 64, 167–176 (1977).PubMedGoogle Scholar
  415. Clendenning, W.E., Brecher, G., Scott, E.J. van: Mycosis fungoides. Relationship to malignant cutaneous reticulosis and the Sézary syndrome. Arch. Derm. Syph. (Chic.) 89, 785–792 (1964).Google Scholar
  416. Cline, R.E., Stenger, T.G.: Histiocytic lymphoma (reticulum cell sarcoma). Report of five cases. Oral. Surg. 43, 422–435(1977).PubMedGoogle Scholar
  417. Clinicopathologic Conference: Lymphoma, lymphocytic type, and hypercalcemia. Amer. J. Med. 48, 367–374 (1970)Google Scholar
  418. Coccia, P.F., Kersey, J.H., Gajl-Peczalska, K.J., et al.: Prognostic significance of surface marker analysis in childhood non-Hodgkin’s lymphoproliferative malignancies. Amer. J. Hemat. 1, 405 (1976).Google Scholar
  419. Cohen, B.B., Kaplan, G., Liber, A.F., Roswit, B.: Reticulum cell sarcoma with primary manifestation in the testis. — Report of four cases. Cancer 8, 136–142 (1955).PubMedGoogle Scholar
  420. Cohen, R.J., Bohannon, R.A., Wallerstein, R.O.: Waldenstrom’s macroglobulinemia — A study of ten cases. Amer. J. Med. 41, 274–284 (1966).PubMedGoogle Scholar
  421. Cohen, H.J., Shimm, D., Paris, S.A., Buckley, C.E., Kremer, W.B.: Hairy cell leukemia-associated familial lymphoproliferative disorder. Ann. intern. Med. 90, 174 (1979).PubMedGoogle Scholar
  422. Cohen, M.I., Widerlite, L.W., Schechter, C.P., Jaffe, E., Fischmann, A.B., Schein, Ph.S., Macdonald, J.S.: Gastrointestinal involvement in the Sézary syndrome. Gastroenterology 73, 145–149 (1977).PubMedGoogle Scholar
  423. Cohen, N.: Lymphosarcoma of the stomach. Gastrointest. Endosc. 8, 16–19 (1961).Google Scholar
  424. Cohnen, G.: Klinisch-diagnostische Bedeutung der Oberflächenmarker menschlicher T- und B-Lymphozyten. Dtsch. med. Wschr. 99, 2302 (1974).PubMedGoogle Scholar
  425. Coleman, N., Vinciguerra, V.P., Lightdale, C.J.: Peritoneoscopy in the staging of Hodgkin’s disease: confirmation of results by laparotomy. Proc. Amer. Soc. Haemat. 329, 154 (1974).Google Scholar
  426. Coley, B.L., Higinbotham, N.L., Groesbeck, H.P.: Primary reticulum-cell sarcoma of bone. Radiology 55, 641–658 (1950).PubMedGoogle Scholar
  427. Coller, F. A., Flotte, C.T.: Lymphomas of the gastro-intestinal tract. Proceedings of Third National Cancer Conference Philadelphia: Lippincott pp. 1957, pp. 753–758.Google Scholar
  428. Collins, A.J., Bloomfield, C.D., Peterson, B.A., McKenna, R.W.: Acute nonlymphocytic leukemia in patients with nodular lymphoma. Cancer 40, 1748–1754 (1977).PubMedGoogle Scholar
  429. Collins, D.H., Pugh, R.C.B.: Classification and frequency of testicular tumors. Brit. J. Urol. 36, 1–11 (1964).PubMedGoogle Scholar
  430. Collins, R., Lukes, R.J.: Studies on the possible derivation of some malignant lymphomas from follicular center cells, abstracted. Amer. J. Path. 62, 63 (1971).Google Scholar
  431. Colman, R.W., Osterland, C.K., Dorfman, R.F., Chaplin, H.: A unique lymphoproliferative disorder associated with an IgM platelet agglutinin, diffuse hypergammaglobulinemia, amyloid deposition and excessive urinary excretion of IgG fragments. Amer. J. Med. 45, 607–618 (1968).PubMedGoogle Scholar
  432. Coltman, C.A., Jr.: Adriamycin (NSC 123127) in the treatment of lymphomas: Southwest Oncology Group studies. Cancer Chemother. Rep. 6, 375–380 (1975).Google Scholar
  433. Constanza, M.E., Pinn, V., Schwartz, R.S., Nathanson, L.: Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. New Engl. J.Med. 289, 520 (1973).Google Scholar
  434. Conti, R.C. de, Hubbard, S.P., Pinch, P., Bertino, J.R.: Treatment of advanced neoplastic disease with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037). Cancer Chemother. Rep. 57, 201–207 (1978).Google Scholar
  435. Cook, H.P.: Oral lymphomas. Oral Surg. 14, 690–704 (1961).PubMedGoogle Scholar
  436. Cook, J.C., Corbett, D.P.: Roentgen therapy of primary gastrointestinal lymphoma. Radiology 78, 562–568 (1962).PubMedGoogle Scholar
  437. Cook, J.C., Krabbenhoft, K.L., Leucutia, T.: Lymphosarcoma, reticulum cell sarcoma, and giant follicular lymphoma. Amer. J. Roentgenol. 84, 656–665 (1960).PubMedGoogle Scholar
  438. Cooke, J.V.: Mediastinal tumor in acute leukemia. A clinical and roentgenologic study. Amer. J. Dis. Child. 44, 1153–1177(1932).Google Scholar
  439. Cooley, J.C., McDonald, J.R., Clagett, O.T.: Primary lymphoma of the lung. Ann. Surg. 143, 18–28 (1956).PubMedGoogle Scholar
  440. Cooper, L.E., Groth, D.P., Vogler, W.R.: Therapeutic effect of recruitement of leukemic cells into cycle by chemotherapeutic manipulations (Abstr.). Amer. Soc. hemat. 130, 130 (1970).Google Scholar
  441. Cooper, M.D., Seligmann, M.: B and T lymphocytes in immunodeficiency and lymphoproliferative diseases. In: Loor, F., Roelants, G.E., B and T cells in immune recognition. London: Wiley 1977.Google Scholar
  442. Cooper, T., Watkins, C.H.: An evaluation of sternal aspirations as an aid in the diagnosis of the malignant lymphomata. Blood 4, 534–549 (1949).PubMedGoogle Scholar
  443. Cooperrider, P.A., Roenigk, H.: Selective immunological evaluation of mycosis fungoides. Arch. Derm. 114, 207–212 (1978).PubMedGoogle Scholar
  444. Copeland, M.M.: Primary malignant tumors of bone: Evaluation of current diagnosis and treatment. Cancer 20, 738–746 (1967).PubMedGoogle Scholar
  445. Corbett, T.H., Griswold, D.P., Mayo, J.G., Laster, W.R., Schabel, F.M.: Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Cancer Res. 35, 1568–1573(1975).PubMedGoogle Scholar
  446. Cornes, J.S.: Hodgkin’s disease of the gastrointestinal tract. Proc. roy. Soc. Med. 60, 732–733 (1967).PubMedGoogle Scholar
  447. Cornes, J.S., Smith, J.C., Southwood, W.: Lymphosarcoma in chronic ulcerative colitis. Brit. J. Surg. 49, 50 (1961).PubMedGoogle Scholar
  448. Cossman, J., Schmitzer, B., Deegan, M.J.: Coexistence of two lymphomas with distinctive histologic, ultrastructural, and immunologic features. Amer. Soc. Clin. Path. 70, 409–415 (1978).Google Scholar
  449. Cotman, H.E., Bloomfield, C.D., Amplatz, K., et al.: Lymphography as a guide during laparotomy in Hodgkin’s and non-Hodgkin’s lymphomas. Acta radiol. ther. phys. biol. (summ, in Germ., Fren.) 16, 295–304(1977).Google Scholar
  450. Couser, W.G., Wagonfeld, J.B., Spargo, B.H., Lewis, E.J.: Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Amer. J. Med. 57, 962 (1974).PubMedGoogle Scholar
  451. Cowan, D.H., Graham, R.J., Jr., Baunach, D.: The platelet defect in leukemia: platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. J. clin. Invest. 56, 188–200 (1975).PubMedGoogle Scholar
  452. Cox, D.R.: The analysis of binary data, pp. 87–90. London: Methuen Co. Ltd. 1970.Google Scholar
  453. Cox, J.D.: Total central lymphatic irradiation for stage III nodular malignant lymphoreticular tumors. Int. J. Radiât. Oncol. Biol. Phys. 1, 491–496 (1976).PubMedGoogle Scholar
  454. Cox, J.D., Koehl, R.H., Turner, W.M., et al.: Malignant lymphoid tumors of lymph nodes in the adult. Arch. Path. 97, 22–28 (1974).PubMedGoogle Scholar
  455. Cox, J.D., Koehl, R.H., Turner, W.M., King, F.M.: Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin’s malignant lymphoma). Radiology 112, 179–185 (1974).PubMedGoogle Scholar
  456. Cox, J.D., Laugier, J.A., Gerard-Marchant, R.: Apparently localized and regionally advanced malignant lymphoreticular tumors in the adult. Cancer 29, 1043–1051 (1972).PubMedGoogle Scholar
  457. Craddock, C.G., Perry, S., Ventzke, L.E., Lawrence, J.S.: Evaluation of marrow granulocyte reserves in normal and disease states. Blood 15, 840–855 (1959).Google Scholar
  458. Craver, L.F.: Some aspects in treatment of Hodgkin’s disease. Cancer 7, 927 (1954).PubMedGoogle Scholar
  459. Craver, L.F., Miller, D.G.: The malignant lymphomas. A monograph for the physician. Amer. Cancer Soc. Inc. 1966.Google Scholar
  460. Cridland, M.D., Green, D.: The management of generalized lymphosarcomatous disease. Med. J. Aust. 55 (II)/5, 195–201 (1968).Google Scholar
  461. Crile, G., Jr., Hazard, J.B., Allen, K.L.: Primary lymphosarcoma of the stomach. Ann. Surg. 135, 39–43 (1952).PubMedGoogle Scholar
  462. Crofts, M.A.J., Sharp, J.C., Joyner, M.V.: Rheumatoid arthritis and hairy-cell leukaemia. Lancet 1979 II, 203.Google Scholar
  463. Crossen, P.E., Meller, J.E.L., Finly, A.C., Ravich, R., Vincent, P.C., Gunz, F.W.: The Sézary syndrome. Cytogenetic studies and identification of the Sézary cell as an abnormal lymphocyte. Amer. J. Med. 50, 24–34 (1971).PubMedGoogle Scholar
  464. Cruveilheir, J.: Anatomie pathologique du corps human. Liv. Sec. 30, Part 2, I, 1827, Paris, 1829.Google Scholar
  465. Cuartero, R.A., Perez Galvez, M.N., Pelaez Redondo, J.: Sindrome de Evans como expresion fundamental de un reticulosarcoma. Rev. clin. esp. 1975 137/2 (1965–1969).Google Scholar
  466. Cubberley, P.T., Polster, S.A., Schulman, C.L.: Lactic acidosis and death after the treatment of obesity by fasting. New Engl. J. Med. 272, 628 (1965).PubMedGoogle Scholar
  467. Cullen, M.H., Lister T.A., Brearley, R.L., Shand, W.S., Stansfeld, A.G.: Histological transformation of non-Hodgkin’s lymphoma. — A prospective study. Cancer 44, 645–651 (1979).PubMedGoogle Scholar
  468. Culver, G.J., Bean, B.C., Berens, D.L.: Gastric lymphoma. Radiology 65, 518 (1955).PubMedGoogle Scholar
  469. Cunningham, J.J.: Lymphography appearance of nodal extramedullary hematopoiesis simulating lymphoma. Lymphology 10, 216–218 (1977).PubMedGoogle Scholar
  470. Cupps, R.E., Hodgson, J.R., Dockerty, M.B., et al.: Primary lymphoma in small intestine: Problems of roentgenologic diagnosis. Radiology 92, 1355–1362 (1969).Google Scholar
  471. Currie, S., Henson, R.A.: Neurological syndromes in the reticuloses. Brain 94, 307–320 (1971).PubMedGoogle Scholar
  472. Custer, R.P.: The changing pattern of lymphocytic malignancies, Internat. Academy of Pathology Monograph pp. 181–193. New York: Hoeber 1960.Google Scholar
  473. Custer, R.P., Bernhard, W.G.: The interrelationship of Hodgkin’s disease and other lymphatic tumors. Amer. J. Med. Sci. 216, 625–642 (1948).PubMedGoogle Scholar
  474. Cyr, D.P., Geokas, M.C., Worsley, G.H.: Mycosis fungoides. Haematological findings and terminal course. Arch. Derm. 94, 558–573 (1966).PubMedGoogle Scholar
  475. Dacie, J.V.: The haemolytic anaemias. Part III. Secondary of symptomatic haemolytic anaemias, pp. 730–731. New York: Grüner & Stratton 1967.Google Scholar
  476. Daems, W.Th., Wisse, E., Brederro, P., Emeis, J.J.: Peroxidase activity in monocytes and macrophages. In: van Fürth, R. (ed.), Mononuclear phagocytes in immunity, infection and pathology, p. 57. Oxford: Blackwell Scientific 1975.Google Scholar
  477. Dahlin, D.C.: Bone tumors, 2nd ed. Springfield, Ill.: Charles C. Thomas 1967.Google Scholar
  478. Dalton, H.P., Gerszten, E., Allison, M.J.: Infections associated with leukemia and lymphoma. Virginia med. Mth. 96, 221 (1969).Google Scholar
  479. Dameshek, W., Brown, S.M., Rubin, A.D.: “Pure” red cell anemia and thymoma. Semin. Hemat. 4, 226–230 (1967).Google Scholar
  480. Dancot, H.: Über die Heilungsaussichten bei Lymphosarkomen und Retikulosarkomen durch Bestrahlung. Strahlentherapie 64, 283 (1967).Google Scholar
  481. Daniel, M.T., Flandrin, G.: Fine structure of abnormal cells in hairy cell (tricholeukocytic) leukemia, with special reference to their in vitro phagocytic capacity. Lab. Invest. 30, 1 (1974).PubMedGoogle Scholar
  482. Dargeon, H.W.: Tumors of childhood: A clinical treatise, pp. 250, 343. Paul B. Hoeber Inc. 1960.Google Scholar
  483. Dargeon, H.W.: Lymphosarcoma in childhood. Amer. J. Roentgenol. 85, 729–732 (1961).PubMedGoogle Scholar
  484. Davey, F.R., Dock, N.L., Terzian, J., Bala, R., Gottlieb, A.J.: Immunological studies in hairy cell leukemia. Arch. Path. Lab. Med. 103, 433 (1979).PubMedGoogle Scholar
  485. Davey, F.R., Goldberg, J., Stockman, J., et al.: Immunologic and cytochemical cell markers in non-Hodgkin’s lymphomas. Lab. Invest. 35, 430–438 (1976).PubMedGoogle Scholar
  486. David, J.R.: Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. nat. Acad. Sci. (Wash.) 56, 72–77 (1966).Google Scholar
  487. Davidson, J.W., Clarke, E.A.: Influence of modern radiological techniques on clinical staging of malignant lymphomas. Can. med. Ass. J. 99, 1196–1204 (1968).PubMedGoogle Scholar
  488. Davies, G.E., Wiernik, P.H.: Hairy cell leukemia with chylous ascites. J. Amer. med. Ass. 238, 1541–1542(1977).Google Scholar
  489. Davis, F.M., Olivetti, R.G.: Primary lymphosarcomatosis of kidneys, adrenal glands and perineal adipose tissue. J. Urol. (Baltimore) 66, 106–114 (1951).Google Scholar
  490. Davis, L.K., Shaw, M.T., Shee, R.T., Bertino, J.R.: Bleomycin, Adriamycin, CCNU and Oncovin combination (BACO) in advanced and recurrent lymphomas. Proc. Amer. Soc. Clin. Onkol. 1977, p. 273.Google Scholar
  491. Davis, Th.E., Waterbury, L., Abeloff, M., Burke, P.J.: Leukemic reticuloendotheliosis. — Report of a case with prolonged remission following intensive chemotherapy. Arch, intern. Med. 136, 620–622 (1976).Google Scholar
  492. Dawson, I.M., Cornes, J.S., Morson, B.C.: Primary malignant lymphoid tumours of the intestinal tract. Brit. J. Surg. 49, 80–89 (1961).PubMedGoogle Scholar
  493. Dayan, A.D., Morgan, H.E., Hope-Stone, H.F., et al.: Disseminated herpes zoster in the reticuloses. Amer. J. Roentgenol. 92, 116–123 (1964).PubMedGoogle Scholar
  494. Debray, Ch., Leymarios, J.: Les hematosarcomes non Hodgkiniens gastro intestinaux. Rev. Prat. (Paris) 26, 1419–1431 (1976).Google Scholar
  495. Debusscher, L., Bernheim, J.L., Collard-Rongé, E., Govaerts, A., Hooghe, R., Leujeune, F.J., Zeicher, M., Stryckmans, P.A.: Hairy cell leukemia: Functional, immunologic, kinetic, and ultrastructural characterization. Blood 46, 495–507 (1975).PubMedGoogle Scholar
  496. Deeb, P.H., Stilson, W.L.: Roentgenologic manifestations of lymphosarcoma of the small bowel. Radiology 63, 235–239(1954).PubMedGoogle Scholar
  497. Deegan, M.J., Cossman, J., Cihosney, T., Schnitzer, B.: Hairy cell leukemia. — An immunologic and ultrastructural study. Cancer 38, 1952–1961 (1976).PubMedGoogle Scholar
  498. Deep, W.D., Fraumeni, J.F., Tashima, C.K., et al.: Leukoencephalopathy and dermatomyositis in Hodgkin’s disease. Arch, intern. Med. 113, 635–640 (1964).Google Scholar
  499. Degos, R., Touraine, R., Civatte, J., Ossipowski, B.: Manifestations cutanées des hémoréticulopathies de l’adulte. Rev. Pract. 13, 2751 (1963).Google Scholar
  500. Deinard, A., Fortuny, I.E., Theologides, A., Anderson, G.L., Boen, J., Kennedy, B.J.: Studies on the neutropenia of cancer chemotherapy. Cancer 33, 1210–1218 (1974).PubMedGoogle Scholar
  501. Delacrétaz, F., Schmidt, P.M.: Intérêt et limites de l’examen combiné cyto-histologique de la moelle hématopoiétique. Schweiz, med. Wschr. 109, 13 (1979).Google Scholar
  502. Delage, J.-M.: Les lymphomes non-Hodgkiniens. Sem. Hôp. (summ, in Engl., Span.) 53, 2415–2423 (1977).Google Scholar
  503. Delbrück, H., Weichert, H.C., Schmitt, G., Firusian, N., Wetter, O.: Der Zusammenhang zwischen Prognose und Kieler Klassifikation der malignen Non-Hodgkin-Lymphome. Eine katamnestische Studie über 201 Patienten. Klin. Wschr. 56, 539–543 (1978).PubMedGoogle Scholar
  504. Delbrück, H., Wetter, O., Schmidt, C.G., Weichert, C., Linder, K.H.: Zur Klinik der malignen follikulären Non-Hodgkin-Lymphome. Dtsch. klin. Wschr. 102, 1273–1279 (1977).Google Scholar
  505. Delbrück, H., Wetter, O., Schmidt, C.G., Weichert, H.C., Schmitt, G.: Die Meningiosis neoplastica und ihre Prophylaxe bei malignen Non-Hodgkin-Lymphomen. Dtsch. med. Wschr. 102, 1446–1451 (1977).PubMedGoogle Scholar
  506. Delgado, G., Smith, J.P., Luis, D., Gallagher, S.: Reticulum cell sarcoma of the cervix. Amer. J. Obstet, gynec. 125, 691–694 (1976).Google Scholar
  507. Dent, D.M., King, H.S., Kahn, L., Jacobs, P.: The value of laparotomy in staging of lymphoma. Surg. Gynec. Obstet. 145, 179–182 (1977).PubMedGoogle Scholar
  508. Desai, D.V., Ezdinli, E.Z., Stutzman, L.: Vincristine therapy of lymphomas and chronic lymphocytic leukemia. Cancer 26, 352–359 (1970).Google Scholar
  509. Desai, P.B., Meher-Homji, D.R., Paymaster, J.C.: Malignant lymphoma. — A clinical study of 800 Indian patients. Cancer 18, 25–33 (1965).Google Scholar
  510. DeSanto, L.W., Weiland, L.H.: Malignant lymphoma of the larynx. Laryngoscope (St. Louis) 80, 966–978 (1970).Google Scholar
  511. Desprez-Curely, J.P.: Ne biopsiez plus d’emblée les ganglions inguinaux. Nouv. Presse méd. 8, 1391 (1979).PubMedGoogle Scholar
  512. Dessauer, F.: Eine neue Anordnung zur Röntgenbestrahlung. Arch. phys. Med. Techn. 2, 218 (1907).Google Scholar
  513. Desser, R.K., Moran, E.M., Ultmann, J.E.: Staging of Hodgkin’s disease and lymphoma. Med. Clin. N. Amer. 57, 479 (1973).PubMedGoogle Scholar
  514. Desser, R.K., Ultmann, J.E.: Risk of severe infection in patients with Hodgkin’s disease or lymphoma after diagnostic laparotomy and splenectomy. Ann. intern. Med. 77, 143–146 (1972).PubMedGoogle Scholar
  515. DeVita, V.T., Bagley, C.M., Goodell, B., et al.: Peritoneoscopy in the staging of Hodgkin’s disease. Cancer Res. 31, 1746 (1971).PubMedGoogle Scholar
  516. DeVita, V.T., Canellos, G.P., Chabner, B.A., Schein, P.S., Hubbard, S., Young, R.C: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1975 I, 248–250.Google Scholar
  517. DeVita, V.T., Canellos, G.P., Schein, P.S., et al.: Malignant lymphoma. — Treatment with combination chemotherapy. Proc. 7th Nat. Cancer Conference 1972, p. 379–390.Google Scholar
  518. DeVita, V.T., Canellos, G.P., Schein, P.S., Chabner, B.A., Bagley, C.M., Young, R.C: Malignant lymphoma. — Treatment with combination chemotherapy. 7th Nat. Cancer Conf. Proceed., pp. 379–390. Philad.: J.B. Lippincott Co. 1973.Google Scholar
  519. DeVita, V.T., Jr., Canellos, G.P., Chagner, B., Schein, P.S., Hubbard, S.P., Young, R.C: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Results with combination chemotherapy. Lancet 1975 I, 248–250.Google Scholar
  520. DeVita, V.T., Jr., Serpick, A.A., Carbone, P.P.: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann. intern. Med. 73, 881–895 (1970).PubMedGoogle Scholar
  521. Dewald, G., Spurbeck, J.L., Vitek, H.A.: Chromosomes in a patient with the Sézary syndrome. Mayo Clin. Proc. 49, 553–557 (1974).PubMedGoogle Scholar
  522. Diamond, H.D.: Hodgkin’s disease: Neurologic sequelae. Mo. Med. 54, 945–956 (1957).PubMedGoogle Scholar
  523. Diamond, L.W., Braylan, R.C.: Cell surface markers on lymphoid cells from Warthin’s tumors. Cancer 44, 580–583 (1979).PubMedGoogle Scholar
  524. Dick, F., Bloomfield, C.D., Brunning, R.D.: Incidence, cytology, and histopathology of non-Hodgkin’s lymphomas in the bone marrow. Cancer 33, 1382–1398 (1974).PubMedGoogle Scholar
  525. Dick, F.R.: Pseudonodular and mixed lymphocytic patterns in the lymph nodes of chronic lymphocytic leukemia patients. Amer. J. clin. Path. 67, 210 (1977).Google Scholar
  526. Dick, F.R., Parks, W., O’Connor, M.: Transformation of nodular lymphoma to an immunoblastic IgM-producing tumor. Amer. J. clin. Path. 68, 611–615 (1977).Google Scholar
  527. Dickler, H.B.: In: Lymphocytes, isolation, fractionation and characterisation, pp.91. Scand. J. Immunol., Suppl. 5 (1976).PubMedGoogle Scholar
  528. Dickler, H.B., Adkinson, N.F., Terry, W.D.: Evidence for individual human peripheral blood lymphocytes bearing both T and B cell markers. Nature (Lond.) 247, 213–215 (1974).Google Scholar
  529. Dickler, H.B., Siegal, F.P., Bentwich, Z., Kunkel, H.G.: Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. Clin. exp. Immunol. 14, 97 (1973).PubMedGoogle Scholar
  530. Dickson, R.: Lymphoma of the larynx. Laryngoscope 81, 578–585 (1971).PubMedGoogle Scholar
  531. Diebold, J.: Classifications des sarcomes lymphoides non-Hodgkiniens et des proliferations voisines. Arch. Anat. path. 23, 97–106 (1975).Google Scholar
  532. Diggs, C.H., Wiernik, P.H.: Cyclophosphamide, Vincristine, and Prednisone (CVP) vs. Cyclophosphamide, Adriamycin, Vincristine and Prednisone (CAVP) for disseminated non-Hodgkin’s lymphomas. Proc. Amer. Soc. Clin. Onkol. 1977, p. 288.Google Scholar
  533. Diggs, C.H., Wiernik, P.H., Sutherland, J.C.: Nodular lymphoma. — Prolongation of survival by complete remission. AACR Abstr. 1979, p. 208.Google Scholar
  534. Ding, J.C., Adams, P.B., Patison, M., et al.: Thymic origin of abnormal lymphoid cells in Sézary syndrome. Cancer 35, 1325 (1975).PubMedGoogle Scholar
  535. Dischler, W., Kriegler, G.: The diagnostic significance of laparoscopy in Hodgkin’s disease. In: Musshoff, K. (ed.) Diagnosis and therapy of malignant lymphoma. Recent Results in Cancer Res., Vol. 46, p. 99. Berlin-Heidelberg-New York: Springer 1974.Google Scholar
  536. Djaldetti, M., Landau, M., Mandel, E.M., Har-Zaav, L., Lewinski, U.: Electron microscopic study of lymphosarcoma cell leukemia. Blut 29, 210–215 (1974).PubMedGoogle Scholar
  537. Djerassi, I., Kim, J.S.: Methotrexate and citrovorum factor rescue in management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin lymphomas). Cancer 38, 1043–1051 (1976).PubMedGoogle Scholar
  538. Djerassi, I., Kim, J.: Methotrexate citrovorum factor in the management of non Hodgkin’s lymphoma: 4 years unmaintained remissions. Proc. Amer. Ass. Cancer Res. 16/66 (1975).Google Scholar
  539. Djordjevic, O., Kostic, L.S., Astaldi, G.: Effect of peptichemio on the growth and survival of isolated mammalian cells. Ost. Z. Onkol. 77, 3–4 (1974).Google Scholar
  540. Djordjevic, O., Kostic, L.S., Astaldi, G.: Effect of peptichemio exposure on DNA synthesis in a mammalian cell system in vitro. Tumori 61, 473–480 (1975).PubMedGoogle Scholar
  541. Dockerty, M.B., Priestly, J.T.: Lymphosarcoma of the testis. J. Urol. (Baltimore) 48, 514–523 (1942).Google Scholar
  542. Doe, W.F.: Alpha chain disease: Clinicopathological features and relationship to so-called mediterranean lymphoma. Brit. J. Cancer (Suppl. II) 31, 350 (1975).Google Scholar
  543. Doe, W.F., Henry, K., Doyle, F.H.: Radiological and histological findings in six patients with alpha-chain disease. Brit. J. Radiol. 49, 3–11 (1976).PubMedGoogle Scholar
  544. Dolan, P.A.: Lymphography. Brit. J. Radiol. 37, 405–415 (1964).PubMedGoogle Scholar
  545. Dollinger, M.R.: Management of recurrent malignant effusions. Chem. Abstr. 22, 138–147 (1972).Google Scholar
  546. Dolman, C.L., Cairns, A.R.: Leukoencephalopathy associated with Hodgkin’s disease. Neurology (Minneap.) 11, 349–353 (1961).Google Scholar
  547. Dominy, D.E., Lucas, R.N.: Pneumocystis carinii infection diagnosed by ante-mortem lung biopsy. Ann. thorac. Surg. 1, 305–310 (1965).Google Scholar
  548. Donaldson, G.W.K., McArthur, M., MacPhermon, A.I.S., Richmond, J.: Blood volume changes in splenomegaly. Brit. J. Haemat. 18, 45 (1970).PubMedGoogle Scholar
  549. Donaldson, S.S., Moore, M.R., Rosenberg, S.A., et al.: Characterization of postsplenectomy bacteremia among patients with and without lymphoma. New Engl. J. Med. 287, 69–71 (1972).PubMedGoogle Scholar
  550. Donlon, J.A., Jaffe, E.S., Braylan, R.C.: Terminal deoxynucleotidyl transferase activity in malignant lymphomas. New Engl. J. Med. 297, 461–464 (1977).PubMedGoogle Scholar
  551. Dorfman, R.F.: Present concepts of the proliferative and malignant diseases of the lymphoreticular tissue. The Leech 31, 10–16 (1961).Google Scholar
  552. Dorfman, R.F.: Follicular (nodular) lymphoma in South Africa: A study of 94 cases. In: Symposion on lymphoreticular tumours in Africa, Paris 1963, pp. 304–326. Basel-New York: S. Karger 1964.Google Scholar
  553. Dorfman, R.F.: Relationship of histology to site in Hodgkin’s disease. Cancer Res. 31, 1786–1793 (1971).PubMedGoogle Scholar
  554. Dorfman, R.F.: Histopathology of the non-Hodgkin’s lymphomas. In: Proc. of the 7th Nat. Cancer Conference, Los Angeles 1972, p. 361. Philadelphia: Lippincott 1973.Google Scholar
  555. Dorfman, R.F.: A newly proposed classification of the non-Hodgkin’s lymphomas. Lancet 1974 I, 1295–1296.Google Scholar
  556. Dorfman, R.F.: Classification of non-Hodgkin’s lymphomas. Lancet 1974 II, 961.Google Scholar
  557. Dorfman, R.F.: The non-Hodgkin’s lymphomas. In: Rebuck, J.W., Berard, C.W., Abell, M.R. (eds.), The reticuloendothelial system, p. 262. Baltimore: Williams & Wilkins Comp. 1975.Google Scholar
  558. Dorfman, R.F.: Pathology of the non-Hodgkin’s lymphomas: New classifications. Cancer Treat. Rep. 61, 945–952 (1977).PubMedGoogle Scholar
  559. Dormart, A., Thierree, A., Modai, J., et al.: Place de la lymphographie dans les états fébriles prolongés et inexpliqués. Ann. Med. Interne 123, 549 (1972).Google Scholar
  560. Drewinko, B., Mavligit, G., Ambus, U., et al.: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell line. J. nat. Cancer Inst. 51, 1377 (1973).PubMedGoogle Scholar
  561. Dudrick, S.J., Rhoads, J.E.: New horizons for intravenous feeding. J. Amer. med. Ass. 215, 939–949 (1971).Google Scholar
  562. Duehmke, E.: Zur klinischen Relevanz der histologischen Differenzierung maligner Non-Hodgkin-Lymphome nach der Kiel Klassifikation. Strahlentherapie 152, 129–139 (1976).Google Scholar
  563. Düllmann, J., Wulfhekel, H., Drescher, S., et al.: Die Haarzellenhämoblastose („hairy cell leukemia“). Klinische, licht- und elektronenmikroskopische Befunde. Dtsch. med. Wschr. 99, 859–863 (1974).PubMedGoogle Scholar
  564. Duhamel, G.: Lymphoid myelofibrosis. Acta haemat. (Basel) 45, 89 (1971).Google Scholar
  565. Duhamel, G., Guerra, L.: Un syndrome hématologique difficile a définir: la myélofibrose lymphoïde. Etude nosologique de six observations. Presse méd. 74, 585 (1966).Google Scholar
  566. Dumont, J., Duffillot, Ch., Flandrin, G., Chelloul, N., Tristant, H., Bernard, J.: Non-Hodgkin’s lymphoma: clinical and immunological data in relation to histology. Brit. J. Cancer 31, Suppl. II, 197–201 (1975).Google Scholar
  567. Dumont, J., Duffillot, C., Thiebaut, F., Chelloul, N., Bernard, J.: Etude de la durée de vie des lympho- et réticulosarcomes en fonction de différents facteurs cliniques et histologiques. Bull. Cancer 61, 51–60(1974).PubMedGoogle Scholar
  568. Dumont, J., Liabeuf, A., Henle, W., Feingold, N., Kourilsky, F.M.: Anti-EBV antibody titers in non-hodgkin lymphomas. Int. J. Cancer 18, 14–23 (1976).PubMedGoogle Scholar
  569. Duncan, S.C., Winkelmann, R.K.: Circulating Sézary cells in hospitalized dermatology patients. Brit. J. Derm. 99, 171 (1978).PubMedGoogle Scholar
  570. Dunn, G.D., Moeller, D., Laing, R.R.: Primary reticulum cell sarcoma of the stomach. Gastrointest. Endosc. 17, 153–158 (1971).PubMedGoogle Scholar
  571. Dunnick, N.R., Castellino, R.A.: Lymphography in patients with suspected malignancy or fever of unexplained origin. Radiology 125, 107–111 (1977).PubMedGoogle Scholar
  572. Dunnick, N.R., Fuks, Z., Castellino, R.A.: Repeat lymphography in non Hodgkin’s lymphoma. Radiology 115, 349–354 (1975).PubMedGoogle Scholar
  573. Dunnick, N.R., Parker, B.R., Castellino, R.A.: Rapid onset of pulmonary infiltration due to histiocytic lymphoma. Radiology 118, 281–285 (1976).PubMedGoogle Scholar
  574. Durant, J.R., Loeb, V., Jr., Dorfman, R., Chan, Y.K.: 1,3 Bis(2 chloroethyl) 1 nitrosurea (BCNU), cyclophosphamide, vincristine and prednisone (BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. Cancer (Philad.) 36, 1936–1944 (1975).Google Scholar
  575. Durant, J.R., Gams, R.A., Dorfman, F.: The lymphoma panel and the SECSG: 8 years and 1,085 cases. Proc. Amer. Soc. Clin. Onkol. 1977, p. 267.Google Scholar
  576. Durepaire, R., Eisenmann, D., Grupper, Ch.: Réticulose maligne avec cellules de Sézary et psoriasis. Bull. Soc. franç. Derm. Syph. 78, 591 (1971).PubMedGoogle Scholar
  577. Durkin, W., Pugh, R., Solomon, J., Rosen, P., Bateman, J.: Intravenous versus intramuscular bleomycin in far-advanced lymphomatous malignancy. Prospective randomized study. ASCO Abstr. Toronto 1976.Google Scholar
  578. Durkin, W.J., Pugh, R.P., Solomon, J., Rosen, P., Pajak, Th.F., Bateman, J.R.: Treatment of advanced lymphomas with bleomycin (NSC-125066). Oncology 33, 140–145 (1976).PubMedGoogle Scholar
  579. Dutcher, T.F., Fahey, J.L.: The histopathology of the macroglobulinemia of Waldenstrom. J. nat. Cancer Inst. 22, 887–917 (1959).PubMedGoogle Scholar
  580. Dutrillaux, B., Lejeune, J.: Sur une nouvelle technique d’analyse du caryotype humaine. C. R. Acad. Sci. (Paris) 272, 1238–1640 (1971).Google Scholar
  581. Dutz, W., Asvadi, S., Sadri, S., et al.: Intestinal lymphoma and sprue: A systematic approach. Gut 12, 804–810 (1971).PubMedGoogle Scholar
  582. Easson, E.C.: The management of Hodgkin’s disease and allied disorders. In: Modem trends in radiotherapy (ed. Deeley, T.J. and Wood, C.A.P.). London: Butterworths 1967.Google Scholar
  583. Easson, E.C., Russel, M.H.: The cure of Hodgkin’s disease. Brit. med. J. 1, 1704–1707 (1963).PubMedGoogle Scholar
  584. Ebbe, S., Wittels, B., Dameshek, W.: Autoimmune thrombocytopenic purpura (“LTP” type) with chronic lymphocytic leucemia. Blood 19, 23–37 (1962).PubMedGoogle Scholar
  585. Ebner, H., Kühböck, J., Pietschmann, H.: Das Sézary-Syndrom. Dermatologica (Basel) 141, 257–269 (1970).Google Scholar
  586. Eckert, H., Smith, J.P.: Malignant lymphoma of the testis. Brit. med. J. 2, 891–894 (1963).PubMedGoogle Scholar
  587. Eddy, H.H.: Parotid tumors. — A review of 138 cases. Aust. N.Z.J. Surg. 40, 1–14 (1970).Google Scholar
  588. Edelson, R., Facktor, M., Andrews, H., Lutzner, M.A., Schein, P.: Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplasts with T-cells by electrophoresis. New Engl. J. Med. 291, 293–294 (1974).PubMedGoogle Scholar
  589. Edelson, R.L.: Recent advances in the cutaneous T-cell lymphomas. Bull. Cancer 64, 209–224 (1977).PubMedGoogle Scholar
  590. Edelson, R.L., Brown, J.A., Grossmann, M., Hardy, M.A.: Anti-thymocyte globulin in treatment of T-cell lymphoma. Lancet 1977 I, 249–250.Google Scholar
  591. Edelson, R.L., Kirkpatrick, C.H., Shevach, E.M., et al.: Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann. intern. Med. 80, 685 (1974).PubMedGoogle Scholar
  592. Edelson, R.L., Kirkpatrick, C.H., Shevach, E.M., Schein, P.S., Smith, R.W., Green, I., Lutzner, M.: Preferential cutaneous infiltration by neoplastic thymus derived lymphocytes. Ann. intern. Med. 80, 685–692 (1974a).PubMedGoogle Scholar
  593. Edelson, R.L., Lutzner, M.A., Kirkpatrick, Ch.H., Shevach, E.M., Green, I.: Morphologic and functional properties of the atypical T lymphocytes of the Sézary syndrome. Mayo Clin. Proc. 49, 558–566 (1974b).PubMedGoogle Scholar
  594. Edelson, R.L., Raafat, J., Berger, C.L., Grossman, M., Troyer, C., Hardy, M.: Antithymocyte globulin in the management of cutaneous T cell lymphoma. Cancer Treat. Rep. 63, 675–680 (1979).PubMedGoogle Scholar
  595. To the Editor: Diffuse histiocytic lymphoma. Ann. intern. Med. 86, 244–245 (1977).Google Scholar
  596. Editorial: Follicular lymphomas. Lancet 1974 I, 1088.Google Scholar
  597. Editorial: Non-renal neoplasms and the kidney. Lancet 1975 I, 24–25.Google Scholar
  598. Editorial: Membrane markers in lymphoproliferative disorders. Lancet 1975 I, 670.Google Scholar
  599. Edmondson, H.A.: Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology. Sect. VII, Fassicle 25, Armed Forces Institute of Pathology, 1958.Google Scholar
  600. Edwards, C.L., Hayes, R.L.: Tumor scanning with 67Ga citrate. J. nucl. Med. 10, 103 (1969).PubMedGoogle Scholar
  601. Edwards, C.L., Hayes, R.L.: Scanning malignant neoplasms with Gallium 67. J. Amer. med. Ass. 212, 1182 (1970).Google Scholar
  602. Ehrlich, A.N., Stalder, G., Geller, W., et al.: Gastrointestinal manifestations of malignant lymphoma. Gastroenterology 54, 1115–1121 (1968).PubMedGoogle Scholar
  603. Eichner, E.: Problems of lymphangiography. Int. Surg. 55, 196–199 (1971).PubMedGoogle Scholar
  604. Eidelman, S., Parkins, A., Rubin, C.E.: Abdominal lymphoma presenting as malabsorption: A clinico-pathologic study of nine cases in Israel and a review of the literature. Medicine (Baltimore) 45, 111–137 (1966).Google Scholar
  605. Eisner, E., Ley, A.B., Mayer, K.: Coombs’-positive hemolytic anemia in Hodgkin’s disease. Ann. intern. Med. 66, 258–273 (1967).PubMedGoogle Scholar
  606. Elechi, E.N., Ali, S.D., Calhoun, T., Kurtz, L.H.: Extra nodal reticulum cell sarcoma of the terminal ileum with intussusception. J. Nat. med. Ass. (N.Y.) 66, 420–423 (1974).Google Scholar
  607. Elias, E.G., Mittelman, A.: The role of surgery in malignant lymphoma. Exhibit presented at the 57th Annual Clinical Congress, Amer. Coll. Surg. Meeting, Atlantic City, Oct. 1971.Google Scholar
  608. Elias, E.G., Mittelman, A.: Lymphoma of head and neck masquerading as carcinoma. Amer. J. Surg. 122, 424–426 (1971).PubMedGoogle Scholar
  609. Elias, E.G., Park, J.S., Mittelman, A.: Exploratory laparotomy for staging of lymphomas. Surgery (St. Louis) 72, 590 (1972).Google Scholar
  610. Ellias, H., Scherrick, J.C.: Morphology of the liver, p. 30. New York: Academic Press 1969.Google Scholar
  611. Elias, L.: Differences in age and sex distributions among patients with non-Hodgkin’s lymphoma. Cancer 43, 2540–2546(1979).PubMedGoogle Scholar
  612. Elias, L., Portlock, C.S., Rosenberg, S.A.: Combination chemotherapy of diffuse histiocytic lymphoma with Cyclophosphamide, Adriamycin, Vincristine and Prednisone (CHOP). Cancer 42, 1705 (1978).PubMedGoogle Scholar
  613. Elke, M.: Angenäherte Bestimmung des Lymphknotenvolumens nach dem Lymphogramm und seiner prozentualen Volumenänderung bei Verlaufskontrollen. Fortschr. Röntgenstr. 112, 398 (1970).Google Scholar
  614. Elke, M.: Indikationen und Gegenindikationen der Lymphographie. Dtsch. med. Wschr. 96, 1399 (1971).PubMedGoogle Scholar
  615. Elke, M.: Röntgendiagnostik bei malignen Lymphomen. Ärztl. Prax. 26, 430 (1974).Google Scholar
  616. Elke, M., Ferstl, A., Schwegler, N.: Aussagewert und Grenzen verschiedener Untersuchungsmethoden bei der Diagnose und Differentialdiagnose im Lymphsystem entwickelter retroperitonealer Tumoren. Radiologe (Berl.) 15, 377–389 (1975).Google Scholar
  617. Elke, M., Ferstl, A., Schwegler, N.: Röntgendiagnostik maligner Lymphome. Diagnostik 9, 264–269 (1976).Google Scholar
  618. Elkon, K.B., Hughes, G.R.V., Catovsky, D., et al.: Hairy-cell leukaemia with polyarteritis nodosa. Lancet 1979 II, 280.Google Scholar
  619. Ellis, L.D., Jensen, W.N., Westerman, M.: Needle biopsy of bone and marrow. Arch. intern. Med. 14, 213–221 (1964).Google Scholar
  620. Ellison, R.G., Bailey, A.W., Yeh, T.I., et al.: Primary lymphosarcoma of the lung. Amer. Surg. 30, 737–744 (1964).Google Scholar
  621. Ellman, L.: Bone marrow biopsy in the evaluation of lymphoma, carcinoma and granulomatous disorders. Amer. J. Med. 1, 60, 1–7 (1976).PubMedGoogle Scholar
  622. Ellman, L., Davis, J., Lichtenstein, N.S.: Uremia due to occult lymphomatous infiltration of the kidneys. Cancer 33, 103–105 (1974).Google Scholar
  623. Emori, H.W., Bluestone, R., Goldberg, L.S.: Pseudo-leukocytosis associated with cryoglobulinemia. Amer. J. clin. Path. 59, 202 (1973).Google Scholar
  624. Emrich, D., Hayes, R.L.: In: Papst, H.W., K. Oeff (Hrsg.), Verhandlungen der Gesellschaft für Nuklearmedizin 1972 (Medico Informationsdienste: Berlin 1975), 81. (Serumbindung von 67-Ga.).Google Scholar
  625. End Results in Cancer Report No. 4: Publication No. (NIH) 73–272. Dept. of Health, Education and Welfare 1972.Google Scholar
  626. Engel, F., McKee, L.C., Bunting, K.: Chromosome 17–18 in leukemias. Lancet 1967 I, 42.Google Scholar
  627. Engle, R.L., Wallis, L.A.: Multiple myeloma and the adult Fanconi syndrome. Amer. J. Med. 22, 5 (1957).PubMedGoogle Scholar
  628. Ennuyer, A., Bataini, P.: Les lymphosarcomes des voies aero-digestives supérieures. Traitement radiothérapique. A propos de 361 cas, formes généralisées exceptées. Nouv. Presse méd. 2, 175 (1973).PubMedGoogle Scholar
  629. Ennuyer, A., Helary, J., Bataini, P.: Résultats de la radiothérapie des lymphoréticulosarcomes des voies aero-digestives supérieures. Statistique de la Foundation Curie. Bull. Ass. franç. Cancer 50, 413 (1963).PubMedGoogle Scholar
  630. Enright, L.P., Trueblood, H.W., Nelsen, T.S.: The surgical diagnosis of abdominal Hodgkin’s disease. Surg. Gynec. Obstet. 130, 853–858 (1970).PubMedGoogle Scholar
  631. E.O.R.T.C.: Bleomycin in the reticulosis. Brit. med. J. 1, 285–286 (1972).Google Scholar
  632. E.O.R.T.C.: Co-operative group for leukaemia and haematosarcomas: Clinical screening of epipodophyllotoxin VM 26 in malignant lymphomas and solid tumors. Brit. med. J. 2, 744 (1972).Google Scholar
  633. Epstein, A.L., Levy, R., Kim, H., et al.: Biology of the human malignant lymphomas. IV. Functional characterization often diffuse histiocytic lymphoma cell lines. Cancer 42, 2379–2392 (1978).PubMedGoogle Scholar
  634. Epstein, E.H., Levin, D.L., Croft, J.D., Lutzner, M.A.: Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy finding, Medicine (Baltimore) 15, 61–72 (1972).Google Scholar
  635. Eraklis, A.J., Kevy, S.V., Diamond, L.K., et al.: Hazard of overwhelming infection after splenectomy in childhood. New. Engl. J. Med. 276, 1225–1229 (1967).PubMedGoogle Scholar
  636. Erskine, J.G., Wang, I., Hutton, M.M.: Chronic granulocytic leukaemia developing upon a follicular lymphoma. Brit. Med. J. 2, 1329 (1977).PubMedGoogle Scholar
  637. Evans, H.L., Butler, J.J., Youness, E.L.: Malignant lymphoma, small lymphocytic type. A clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma. Cancer 41, 1440–1455 (1978).PubMedGoogle Scholar
  638. Everett, C.R., Haggard, M.E., Levin, W.C.: Extensive leukemic infiltration of the gastrointestinal tract during apparent remission in acute leukemia. Blood 22, 92 (1963).Google Scholar
  639. Everson, T.C., Cole, W.H.: Spontaneous regression of cancer. Philadelphia: Saunders 1966.Google Scholar
  640. Ewald, O.: Die leukämische Reticuloendotheliose. Dtsch. Arch. klin. Med. 142, 222 (1923).Google Scholar
  641. Ewy, G.A., Jones, S., Yauger, H., Groves, B., Gaines, J.: Adriamycin cardiac toxicity: Potentiation by thoracic radiation. Clin. Res. 24, 120 A (1976).Google Scholar
  642. Exelby, P.R.: Method of evaluating children with Hodgkin’s disease. Chem. Abstr. 21, 95–101 (1971).Google Scholar
  643. Ezdinli, E., Costello, W., Carbone, P.P. for Eastern Cooperative Oncology Group: Chemotherapy response and survival in diffuse versus nodular poorly differentiated lymphocytic lymphoma (LPD). AACR Abstr. 1977, p. 74.Google Scholar
  644. Ezdinli, E., Pocock, S., Berard, C.W., Aungst, C.W., Silverstein, M., Horton, J., Bennett, J., Bakemeier, R., Stolbach, L., Perlia, C., Brunk, F., Lenilard, R., Klaassen, J., Richter, P., Carbone, P.: Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas. — A progress report. Cancer 38, 1060–1068 (1976).PubMedGoogle Scholar
  645. Ezdinli, E.Z., Costello, W.G., Icli, F., et al.: Nodular mixed lymphocytic-histiocytic lymphoma (NM). Response and survival. Cancer 45, 261–267 (1980).PubMedGoogle Scholar
  646. Ezdinli, E.Z., Costello, W., Lenhard, R.E., et al.: Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma. Cancer 41, 1990–1996 (1978).Google Scholar
  647. Ezdinli, E.Z., Pocock, S., Brunk, S.F., et al.: Intensive versus moderate chemotherapy of lymphocytic lymphoma. Proc. Amer. Ass. Cancer Res. 15, 39 (1974).Google Scholar
  648. Fabre, J., Delsol, G., Fedou, R., et al.: Etude des lésions hépatiques de la »hairy cell leukemia«. Virchows Arch. Abt. B 15, 139–156 (1974).Google Scholar
  649. Fahimi, H.D.: The fine structural localization of endogenous and exogenous peroxidase activity in Kupffer cells of rat liver. J. Cell. Biol. 47, 247 (1970).PubMedGoogle Scholar
  650. Fahimi, H.D., Gray, B.A., Herzog, V.K.: Cytochemical localization of catalase and peroxidase in sinusoidal cells of rat liver. Lab. Invest. 34, 192 (1976).PubMedGoogle Scholar
  651. Fairley, N.H., Mackie, F.P.: Clinical and biochemical syndrome in lymphadenoma and allied diseases involving the mesenteric lymph glands. Brit. med. J. 1, 375–380 (1937).PubMedGoogle Scholar
  652. Falkson, G., Van Dyk, J.J., Van Eden, E.B., et al.: A clinical trial of the oral form of 4′-demethylepipodophyllotoxin-ß-D-ethylidene glucoside (NSC 141540) VP 16–213. Cancer 35, 1141–1144 (1975).PubMedGoogle Scholar
  653. Faraci, R.P., Hoffstrand, H.J., Witebsky, F.G., et al.: Malignant lymphoma of the jejunum in a patient with Wiskott Aldrich syndrome. Arch. Surg. 110, 218–220 (1975).PubMedGoogle Scholar
  654. Faris, T.D., Saltzstein, S.L.: Gastric lymphoid hyperplasia: A lesion confused with lymphosarcoma. Cancer 17, 207–212 (1964).PubMedGoogle Scholar
  655. Fauci, A.S., Haynes, B.F., Katz, P.: The spectrum of vasculitis. Ann. intern. Med. 89, 660 (1978).PubMedGoogle Scholar
  656. Faulkner, J.W., Dockerty, M.B.: Lymphosarcoma of the small intestine. Surg. Gynec. Obstet. 95, 76–84 (1952).PubMedGoogle Scholar
  657. Fay, J.W., Moore, J.O., Logue, G.L., Huang, A.T.: Leukophoresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia). Blood 54, 747 (1979).PubMedGoogle Scholar
  658. Feiner, A.S., Myers, A.M., Moore, G.E.: Leukemic reticuloendotheliosis loss of platelet defect after splenectomy. J. Amer. med. Ass. 240, 238–240 (1978).Google Scholar
  659. Feld, R., Bodey, G.P.: Significant infections in patients with malignant lymphoma treated with chemotherapy, Proc. Amer. Ass. Cancer Res. 16, 237 (1975).Google Scholar
  660. Feld, R., Bodey, G.P., Gröschel, D.: Mycobacteriosis in patients with malignant disease. Arch. intern. Med. 136, No. 1, 67–70 (1976).PubMedGoogle Scholar
  661. Feldman, F., Kanter, I.E., Fleming, R.J., et al.: Simultaneous arterial and venous angiography in the evaluation of anterior mediastinal tumors. Radiology 93, 1281–1289 (1969).PubMedGoogle Scholar
  662. Ferguson, D.J., Allen, L.W., Griem, M.L., Moran, E.M., Rappaport, H., Ultman, J.E.: Surgical experience with staging laparotomy in 125 patients with lymphoma. Arch. intern. Med. 131, 356–361 (1973).PubMedGoogle Scholar
  663. Fergusson, J.D.: Tumours of the testis. Brit. J. Urol. 34, 407–421 (1962).PubMedGoogle Scholar
  664. Ferrant, A., Rodhain, J., Michaux, J.L., et al.: Detection of skeletal involvement in Hodgkin’s disease: A comparison of radiography, bone scanning and bone marrow biopsy in 38 patients. Cancer 35, 1346–1353 (1975).PubMedGoogle Scholar
  665. Ferrarini, M., Hoffman, Th., Fu, S.M., Winchester, R., Kunkel, H.G.: Receptors for IgM on certain human B-lymphocytes. J. Immunol. 119, 1525–1529 (1977).PubMedGoogle Scholar
  666. Ferrucci, J.T., Jr.: Body ultrasonography (first of two parts). New Engl. J. Med. 300, 538 (1979).PubMedGoogle Scholar
  667. Ferrucci, J.T., Jr.: Body ultrasonography (second of two parts). New Engl. J. Med. 300, 590 (1979).PubMedGoogle Scholar
  668. Feuerman, E.J., Sandbank, M.: Lymphomatoid papulosis. Arch. Derm. 105, 233–235 (1972).PubMedGoogle Scholar
  669. Fialkow, P.J.: Immunologic oncogenesis. Blood 30, 388 (1967).PubMedGoogle Scholar
  670. Ficari, A.: A case of lymphosarcoma with metastasis in unusual situations. J. Path. Bact. 62, 103–111 (1950).PubMedGoogle Scholar
  671. Field, M., Block, J.B., Leon, R., et al.: Significance of blood lactate elevations among patients with acute leukemia and other neoplastic proliferative disorders. Amer. J. Med. 40, 528–547 (1966).Google Scholar
  672. Filippa, D.A., Lieberman, P.H., Erlandson, R.A., et al.: A study of malignant lymphomas using light and ultramicroscopic, cytochemical and immunologic technics. Correlation with clinical features. Amer. J. Med. 64, 259–268 (1978).PubMedGoogle Scholar
  673. Fink, K., Al-Mondhiry, H.: Idiopathic thrombocytopenic purpura in lymphoma. Cancer 37, 1999–2004 (1976).PubMedGoogle Scholar
  674. Fink, M.E., Calabresi, P.: The granulocyte response to endotoxin (pyrexal) as a measure of functional marrow reserve in cancer chemotherapy. Ann. intern. Med. 57, 732–742 (1962).Google Scholar
  675. Firat, D., Stutzman, L., Studenski, E.R., Pickren, J.: Giant follicular lymph node disease. Amer. J. Med. 39, 252–259 (1965).PubMedGoogle Scholar
  676. Fischer, W., Fölsch, E.: Wandlungen in der Diagnose und Therapie des Lymphosarkoms und Retikulosarkoms. Dtsch. med. Wschr. 12, 630 (1975).Google Scholar
  677. Fischmann, A.B., Bunn, P.A., Cuccion, J.G., Matthews, M.J., Minna, J.D.: Exposure to chemicals, physical agents, and biologic agents in Mycosis fungoides and the Sezary-Syndrome. Cancer Treat. Rep. 63, 591–596 (1979).PubMedGoogle Scholar
  678. Fisher, A.M., Kendall, B., van Leuven, B.D.: Hodgkin’s disease: A radiological survey. Clin. Radiol. 13, 115–127 (1962).PubMedGoogle Scholar
  679. Fisher, B., Fisher, E.R.: Host factors influencing the development of metastases. Surg. Clin. N. Amer. 42, 335–351 (1962).PubMedGoogle Scholar
  680. Fisher, E.R., Davis, E.R., Lemmen, J.J.: Reticulum-cell sarcoma of brain (microglioma). Arch. Neurol. (Chic.) 81, 591–598 (1959).Google Scholar
  681. Fisher, R.I., Johnson, B.L., Simon, R., Schein, P.S., DeVita, V.T., Young, R.C.: Factors influencing survival of Diffuse Histiocytic Lymphoma (DHL) following combination chemotherapy. ASCO Abstr. 1976, p. 257.Google Scholar
  682. Fisher, R.I., DeVita, V.T., Jonson, B.L., Simon, R., Young, R.C.: Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Amer. J. Med. 63, 177–182 (1977).PubMedGoogle Scholar
  683. Fishman, W.H.: Perspectives on alkaline phosphatase isoenzymes. Amer. J. Med. 56, 617–650 (1974).PubMedGoogle Scholar
  684. Fishman, W.H., Bardawil, W.A., Habib, H.G., Anstiss, C.L., Green, S.: The placental isoenzyme of alkaline phosphatase in sera of normal pregnancy. Amer. J. clin. Path. 57, 65–74 (1971).Google Scholar
  685. Fitzgerald, P.H., Adams, A.: Chromosome studies in chronic lymphocytic leukemia and lymphosarcoma. J. nat. Cancer Inst. 34, 827 (1965).PubMedGoogle Scholar
  686. Flaherty, M.J., Poindexter, J., Pajak, T.F., Nissen, N.I., Moon, J.H.: Comparative study of vincristine and cyclophosphamide dosing and scheduling in non-Hodgkin’s lymphoma. Proc. Amer. Soc. Clin. Onkol. 1977, p. 305.Google Scholar
  687. Flandrin, G., Boiron, M., Lasneret, J., Ripault, J., Lotholary, P., Tänzer, J., Bernard, J.: Etude par biopsie des infiltrations lymphocytaires de la mœlle osseuse. Presse méd. 75, 2497–2502 (1967).PubMedGoogle Scholar
  688. Flandrin, G., Ripault, J.: Histiolymphocytose médullaire et splénique de l’adulte: étude de 19 cas. Actual. Hémat. 3e série, 18–19. Masson et Cie, Paris 1969.Google Scholar
  689. Flandrin, G., Brouet, J.C.: The Sézary cell: cytologie, cytochemical and immunologie studies. Mayo Clin. Proc. 49, 575–583 (1974).PubMedGoogle Scholar
  690. Flandrin, G., Brouet, J.C., Daniel, M.T., Preud’homme, J.L.: Acute leukemia with Burkitt’s tumor cells. A study of six cases with special reference to lymphocyte surface markers. Blood 45, 183 (1975).PubMedGoogle Scholar
  691. Flandrin, G., Daniel, M.T.: B-Glucoronidase activity in Sézary cells. Scand. J. Haemat. 12, 23–31 (1974).Google Scholar
  692. Flandrin, G., Daniel, M.T., Fourcade, M., Chelloul, N.: Leucémie a »tricholeucocyte« (hairy cell leukemia) étude clinique et cytologique de 55 observations. Nouv. Rev. franç. Hémat. 13, 609–640 (1973).PubMedGoogle Scholar
  693. Flaxman, B.A., Zelazny, G., Scott, E.J. van: Nonspecificity of characteristic cells in mycosis fungoides. Arch. Derm. 104, 141 (1971).PubMedGoogle Scholar
  694. Fleischmajer, R., Eisenberg, S.: Sézary’s reticulosis. Its relationship with neoplasias of the lymphoreticular system. Arch. Derm. 89, 9–19 (1964).PubMedGoogle Scholar
  695. Fleischman, E.W., Prigogina, E.L.: G banding in cytogenetic study of hemoblastoses. Humangenetik 26, 335–342 (1975).PubMedGoogle Scholar
  696. Fleischman, E.V., Prigogina, E.L., Platonova, G.M., Chudina, A.P., Kruglova, G.V., Kaverzneva, M.M.: Comparative chromosome characteristics of reticulosarcomas and Hodgkin’s disease. Neoplasma 21, 51–61 (1974).PubMedGoogle Scholar
  697. Fleischman, T., Hakansson, C.H., Levan, A.: Fluorescent marker chromosomes in malignant lymphomas. Hereditas (Lund) 69, 311–314 (1971).Google Scholar
  698. Fleischman, T., Hakanson, C.H., Levan, A., Möller, T.: Multiple chromosome aberrations in a lymphosarcomatous tumor. Hereditas (Lund) 70, 243–258 (1972).Google Scholar
  699. Fleischner, F.G., Bernstein, G., Levine, B.E.: Retrosternal infiltration in malignant lymphoma. Radiology 51, 350–357 (1948).PubMedGoogle Scholar
  700. Foadi, M.D., Pegrum, G.D., Bagshawe, K.D.: Bone marrow appearance in reticulum cell sarcoma. Acta haemat. (Basel) 54, 1–10 (1975).Google Scholar
  701. Földi, M.: Erkrankungen des Lymphsystems, 2. Aufl. Baden-Baden: Witzstock 1971.Google Scholar
  702. Forcier, R.J.: Combination chemotherapy of advanced lymphoma (Abstr.). Amer. Soc. of Clin. Oncology, San Francisco 1969.Google Scholar
  703. Forcier, R.J., McIntyre, O.R., Nissen, N.I., Holland, J.F., Glidewell, O., Pajak, T.F.: Combination chemotherapy of non Hodgkin’s lymphoma. A study of the CALGB. Med. Pediat. Oncol. 4, 351–362 (1978).Google Scholar
  704. Ford, W.L., Gowans, J.L.: The traffic of lymphocytes. Sem. Haemat. 6, 67 (1969).Google Scholar
  705. Forrest, J.V.: Radiographic findings in Pneumocystis carinii pneumonia. Radiology 103, 539–544 (1972).PubMedGoogle Scholar
  706. Fortuny, I.E., Theologides, A., Hadlock, D.C., Kennedy, B.J., Deinard, A.: Neutrophil leukocyte reserves in lymphoreticular malignancies. Med. Ped. One. 2, 167–172 (1976).Google Scholar
  707. Foster, S.C., Wilson, C.S., Tretter, P.K.: Radiotherapy of primary lymphoma of the orbit. Amer. J. Roentgenol. 111, 343–349 (1971).PubMedGoogle Scholar
  708. Fox, J.E.B., Hillcoat, B.L.: Inactivation of dihydrofolate reductase in vitro by binding to microsomal membranes. Biochem. Biophys. Res. Commun. 73, 562–568 (1976).PubMedGoogle Scholar
  709. Franchini, A., Tonielli, E., Calo, G.: La laparosplenectomia nei linfomi non Hodgkin. Acta chir. ital. 33, 594–598 (1977) (summ, in Engl.).Google Scholar
  710. Francis, K.C., Higinbotham, N.L., Coley, B.L.: Primary reticulum cell of bone. — Report of 44 cases. Surg. Gynec. Obstet. 99, 142–146 (1954).Google Scholar
  711. Franken, Th., Frommhold, H., Thurn, P.: Zur Strahlentherapie und zum Ausbreitungsmodus von Non-Hodgkin-Lymphomen. Strahlentherapie 153, 40–45 (1977).PubMedGoogle Scholar
  712. Franklin, C.I.V.: Primary lymphoreticular tumours in the orbit. Clin. Radiol. 26, 137–140 (1975).PubMedGoogle Scholar
  713. Fraser, J.F., Schwartz, H.J.: Neoplastic disease of the reticulo-endothelial system. Arch. Derm. Syph. (Chic.) 33, 1–11 (1936).Google Scholar
  714. Frazer, J.W., Jr: Malignant lymphomas of the gastrointestinal tract. Surg. Gynec. Obstet. 108, 182–190 (1959).PubMedGoogle Scholar
  715. Freeman, C., Berg, J.W., Cutler, S.J.: Occurrence and prognosis of extranodal lymphomas. Cancer 29, 252–260 (1972).PubMedGoogle Scholar
  716. Frei, E. III, Freireich, E.J.: Progress and perspective in the chemotherapy of acute leukemia. In: Advances in chemotherapy, Vol. 2, pp. 269–298. New York: Academic Press 1965.Google Scholar
  717. Frei, E. III, Luce, J.K., Gamble, J.F., et al.: Combination chemotherapy in advanced Hodgkin’s disease. Ann. intern. Med. 79, 376–382 (1973).PubMedGoogle Scholar
  718. Frei, E. III, Luce, J.K., Talley, R.W., Vaitkevicius, V.K., Wilson, H.E.: 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma. Cancer. Chemother. Rep. 56, 667–670 (1972).PubMedGoogle Scholar
  719. Frias, A., Sullivan, M.P.: Convoluted Cell Lymphoma (CCL) and “T” Cell Leukemia (TCL): Survival, patterns of relapse and rescue with LSA2-L2 therapy. Proc. Amer. Soc. Clin. Onkol. 1977, p. 305.Google Scholar
  720. Friedman, A.I.: Primary lymphosarcoma of the stomach. A clinical study of seventy-five cases. Amer. J. Med. 26, 783 (1959).PubMedGoogle Scholar
  721. Friedman, H.B., Scher, G.M., Brown, C.H.: Lymphoma of the colon simulating ulcerative colitis: A report of four cases. Amer. J. dig. Dis. 13, 910 (1968).PubMedGoogle Scholar
  722. Friedman, M., Kim, T.H., Panahon, A.M.: Spinal cord compression in malignant lymphoma. Cancer 37, 1485–1491 (1976).PubMedGoogle Scholar
  723. Friedman, N.H., Covey, W.G.: Hairy cell leukemia. A case report. Conn. Med. 38, 342 (1974).PubMedGoogle Scholar
  724. Frizzera, G., Murphy, S.B.: Follicular (nodular) lymphoma in childhood: A rare clinical-pathological entity: Report of eight cases from four cancer centers. Cancer 44, 2218 (1979).PubMedGoogle Scholar
  725. Froland, S.S., Wisloff, F., Michaelsen, T.E.: Human lymphocytes with receptors for IgG. A population of cells distinct from T- and B-lymphocytes. Int. Arch. Allergy 47, 124–138 (1974).PubMedGoogle Scholar
  726. Fromke, V.L., Weber, L.W.: Extensive leukemic infiltration of the gastrointestinal tract in chronic lymphosarcoma cell leukemia. Amer. J. Med. 56, 879 (1974).PubMedGoogle Scholar
  727. Front, D., Hardoff, R., Yoselevski, G., Robinson, E.: Scintigraphy of the skull and facial bones. J. Amer. med. Ass. 239, 2597–2598 (1978).Google Scholar
  728. Fu, K., Stewart, J.R.: Radiotherapeutic management of small intestinal lymphoma with malabsorption. Cancer 31, 286–290 (1973).PubMedGoogle Scholar
  729. Fu, S.M., Winchester, R.J., Feizi, T., Walzer, P.D., Kunkel, H.G.: Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc. nat. Acad. Sci. (Wash.) 71, 4487–4490 (1974).Google Scholar
  730. Fu, S.M., Winchester, R.J., Kunkel, H.G.: Occurrence of surface IgM, IgD, and free light chains on human lymphocytes. J. exp. Med. 139, 451–456 (1974).PubMedGoogle Scholar
  731. Fu, S.M., Winchester, R.J., Kunkel, H.G.: The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J. exp. Med. 142, 1335–1338 (1975).Google Scholar
  732. Fu, S.M., Winchester, R.J., Kunkel, H.G.: Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J. Immunol. 114, 250–252 (1975).PubMedGoogle Scholar
  733. Fu, S.M., Winchester, R.J., Rai, K.R., Kunkel, H.G.: Hairy cell leukemia: proliferation of a cell with phagocytic and B-lymphocyte properties. Scand. J. Immunol. 3, 847–851 (1974).PubMedGoogle Scholar
  734. Fu, Y.S., Perzin, K.H.: Lymphosarcoma of the small intestine: A clinicopathologic study. Cancer 29, 645–659 (1972).PubMedGoogle Scholar
  735. Fuchs, W.A., Davidson, J.W., Fischer, H.W.: Lymphography in cancer. Berlin-Heidelberg-New York: Springer 1969.Google Scholar
  736. Fuks, Z., Glatstein, E., Kaplan, H.S.: Patterns of presentation and relapse in the non-Hodgkin’s lymphomata. Brit. J. Cancer 31, Suppl. II, 286–297 (1975).Google Scholar
  737. Fuks, Z., Glatstein, E., Kaplan, H.S.: Non-Hodgkin’s lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 37, 1806–1812 (1976).Google Scholar
  738. Fuks, Z., Kaplan, H.S., Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 108, 675–684 (1973).PubMedGoogle Scholar
  739. Fuks, Z., Strober, S., Kaplan, H.S.: Interaction between serum factors and T lymphocytes in Hodgkin’s disease. New Engl. J. Med. 295, 1273–1277 (1976).PubMedGoogle Scholar
  740. Fuks, Z.Y., Bagshaw, M.A.: Total skin electron treatment of mycosis fungoides. Ther. Radiol. 100, 145–150 (1971).Google Scholar
  741. Fuks, Z.Y., Bagshaw, M.A., Farber, E.M.: Prognostic signs and the management of the mycosis fungoides. Cancer 32, 1385–1395 (1973).PubMedGoogle Scholar
  742. Fuks, Z., Hoppe, R.T., Bagshaw, M.A.: The role of total skin irradiation with electrons in the management of mycosis fungoides. Bull. Cancer 64, 291–304 (1977).PubMedGoogle Scholar
  743. Fukuda, T.: Malignant reticulosis. Tohoku J. exp. Med. 94, 351 (1968).PubMedGoogle Scholar
  744. Fukuhara, S., Shirakawa, S., Uchino, A.: Specific marker chromosome 14 in malignant lymphomas. Nature 259, 210 (1976).PubMedGoogle Scholar
  745. Fuller, L.M.: Results of large volume irradiation in the management of Hodgkin’s disease and malignant lymphomas originating in the abdomen. Radiology 87, 1058–1064 (1966).PubMedGoogle Scholar
  746. Fuller, L.M.: Results of intensive regional radiation therapy in the treatment of Hodgkin’s disease and the malignant lymphomas of the head and neck. Amer. J. Roentgenol. 99, 340–351 (1967).PubMedGoogle Scholar
  747. Fuller, L.M., Banker, F.L., Butler, J.J., Gamble, J.F., Sullivan, M.P.: The natural history of non-Hodgkin’s lymphomas stages I and II. Brit. J. Cancer 31, Suppl. II, 270 (1975).Google Scholar
  748. Fuller, L.M., Fletcher, G.H.: Radiotherapeutic management of lymphomatous diseases. Amer. J. Roentgenol. 88, 909–923 (1962).PubMedGoogle Scholar
  749. Fuller, L.M., Gamble, J.F., Butler, J.J., Sinkovics, J.G., Wallace, S., Martin, R.G., Gehan, E.A., Shullenberger, C.C.: Team approach to management of non-Hodgkin’s lymphoma: Past and present. Cancer Treat. Rep. 61, 1137 (1977).PubMedGoogle Scholar
  750. Gadrat, J., Ribet, A., Suduca, P., et al.: Le lymphoreticulo-sarcoma gastrique: A propos de deux observations: inte et de la biopsie dirigée sous contrôle endoscopique. Arch. franc. Mal. Appar. dig. 57, 260 (1968).Google Scholar
  751. Gaedicke, G., Winkler, K., Petersen, N., et al.: Das maligne mediastinale lymphoblastische Lymphom mit leukämischem Verlauf. Klin. Pädiatr. 189/1, 31–36 (1977).PubMedGoogle Scholar
  752. Gaerhart, P.J.: Non-sequential expression of multiple immunoglobulin classes by isolated B-cell clones. Nature 812, 269 (1977).Google Scholar
  753. Gaetani, C.F. De, Sannicola Botticelli, C., Rigo, G.P.: Primary gastric lymphoplasmacytoid malignant lymphoma (gastric plasmacytoma): an endoscopic cytologic diagnosis. Acta Cytol. (Philad.) 21, 465–468 (1977).Google Scholar
  754. Gagliano, R.G., Costanzi, J.J., Beathard, G.A., Sarles, H.E., Bell, J.D.: The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Report of a case and review of the literature. Amer. J. Med. 60, 1026–1031 (1976).PubMedGoogle Scholar
  755. Gahrton, G., Lindsten, J., Zech, L.: Involvement of chromosomes 8, 9, 19 and 22 in Ph1 positive and Ph1 negative chronic myelocytic leukemia in the chronic or blastic stage. Acta med. scand. 196, 355–360 (1974).PubMedGoogle Scholar
  756. Gajl-Peczalska, K.J., Bloomfield, C.D., Coccia, P.F., Sosin, H., Brunning, R.D., Kersey, J.H.: B and T cell lymphomas. Amer. J. Med. 59, 674–685 (1975).PubMedGoogle Scholar
  757. Gajl-Peczalska, K.J., Hansen, J.A., Bloomfield, C.D., Good, R.A.: B lymphocytes in untreated patients with malignant lymphoma and Hodgkin’s disease. J. clin. Invest. 52, 3064 1973).PubMedGoogle Scholar
  758. Gall, E.A.: The surgical treatment of malignant lymphoma. Ann. Surg. 118, 1064–1070 (1943).PubMedGoogle Scholar
  759. Gall, E.A., Mallory, T.B.: Malignant lymphoma: clinico-pathologic survey of 618 cases. Amer. J. Path. 18, 381–429 (1942).Google Scholar
  760. Gall, J.A., Sartiano, G., Deutsch, M.: Primary reticulum cell sarcoma of the uterus. Oncology (Basel) 31, 157–163 (1975).Google Scholar
  761. Gallais, H., Saladini, P.L.: La biopsie osteo médullaire dans les lympho et reticulo sarcomes. Mediterr. Med. 3, 15–56 (1975).Google Scholar
  762. Galton, D.A.G., Catovsky, D., Wiltshaw, E.: Clinical spectrum of lymphoproliferative diseases. Cancer 42, 901 (1978).PubMedGoogle Scholar
  763. Curto Gamallo, J.M., Sanchis Cabanilles, M.: Reticulosarcoma primario de hueso (revision bibliografica y presentacion de un caso clinico). Rev. Esp. Cir. Osteoartic. 9, 411–417 (1974).Google Scholar
  764. Gamble, J.F., et al.: Combination (COP) chemotherapy of malignant lymphoma in adults (abstr.). Amer. Soc. Clin. Oncol. 1967.Google Scholar
  765. Gardner, F.H., Pringle, J.C., Jr.: Androgens and erythropoiesis. Arch, intern. Med. 107, 846 (1961).Google Scholar
  766. Garfein, O.B.: Lymphosarcoma of the right atrium. Arch, intern. Med. 135, 325 (1975).Google Scholar
  767. Garrett, M.J., Das, S.: A preliminary study in treatment of non-Hodgkin’s lymphoma by whole-body irradiation. Clin. Radiol. 27, 409–414 (1976).PubMedGoogle Scholar
  768. Garrett, T.J., Gee, T.S., Dowling, M.D., Lee, B.J., Middleman, M.P., Clarkson, B.D., Young, C.W.: Cyclophosphamide L2 protocol: A combination chemotherapeutic regimen for advanced non-Hodgkin’s lymphoma. Cancer Treat. Rep. 61, 7–16 (1977).PubMedGoogle Scholar
  769. Garwicz, S., Landberg, T., Lindberg, L.-G., Akerman, M.: Clinico-pathological correlations in the Kiel classification of non-Hodgkin’s lymphomata in children. Scand. J. Haemat. 171–180 (1978).Google Scholar
  770. Gasparini, M., Spinelli, P., Fossati Bellani, F., Bonadonna, G., Monfardini, S.: Laparoscopy (LS) in staging and restaging childhood neoplasia. ASCO Abstr., Toronto 1976.Google Scholar
  771. Gastaut, J.A., Gastaut, J.L., Carcassonne, Y.: Computerized axial tomography in the study of intracranial complications in hematology. Cancer 41, 487–501 (1978).PubMedGoogle Scholar
  772. Gebbers, J.O., Otto, H.F., Müller-Wieland, K.: Immunoblastisches Sarkom („Retikulumzellsarkom“) des Gastrointestinaltraktes bei Dermatitis herpetiformis Duhring. Dtsch. med. Wschr. 102, 242–247 (1977).PubMedGoogle Scholar
  773. Gechman, E., Bluth, I., Gross, J.M.: Hodgkin’s disease of the rectum. Arch, intern. Med. 97, 483–491 (1956).Google Scholar
  774. Gendelman, S., Rizzo, F., Mones, R.J.: Central nervous system complications of leukemic conversion of the lymphomas. Cancer 24, 676–682 (1969).PubMedGoogle Scholar
  775. Gérard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A.G., Unnik, J.A.M. van: Classification of non-Hodgkin’s lymphomas. Lancet 2/1, 406–408 (1974).Google Scholar
  776. Gerrard, J.M., Stoddard, S.F., Shapiro, R.S., Coccia, P.F., Ramsay, N.K.C., Nesbit, M.F., Rao, G.H.R., Krivit, W., White, J.G.: Platelet storage pool deficiency and prostglandin synthesis in chronic granulocytic leukaemia. Brit. J. Haemat. 40, 597–607 (1978).PubMedGoogle Scholar
  777. Gerteis, W.: Darstellungsmethoden des Lymphgefäßsystems und praktische Lymphographie. In: Meessen, H., Handbuch der allgemeinen Pathologie, Lymphgefäßsystem. Bd. 3, Teil 6, S. 595. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  778. Gerundo, M., Miller, M.B.: Reticulum-cell sarcoma of spleen. Amer. J. Cancer 35, 528–533 (1939).Google Scholar
  779. Ghadially, F.N., Skinnider, L.F.: Ultrastructure of hairy cell leukemia. Cancer 29, 444 (1972).PubMedGoogle Scholar
  780. Ghosh, L., Muehrcke, R.C.: The nephrotic syndrome: a prodrome to lymphoma. Ann. intern. Med. 72, 379 (1970).PubMedGoogle Scholar
  781. Gianadda, B., Robart, S., Brutzkus, A., Perrot, H.: Mycosis fongoïde et dysglobulinémie monoclonale. Ann. Derm. Venereol. (Paris) 107, 71–74 (1980).Google Scholar
  782. Gilbert, E.H., Earle, J.D., Goris, M.L., et al.: The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology 119, 167–168 (1976).PubMedGoogle Scholar
  783. Gilbert, E.H., Glatstein, E., Goris, M.L., Earle, J.D.: Value of 111Indium chloride bone marrow scanning in the differential diagnosis of blood count depression in lymphoma. Cancer 143–152 (1978).Google Scholar
  784. Gilchrest, B.A.: Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat. Rep. 63, 663–667 (1979).PubMedGoogle Scholar
  785. Gilchrest, B.A., Parrish, J.A., Tanenbaum, L., Haynes, H.A., Fitzpatrick, T.B.: Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 38, 683–689 (1976).PubMedGoogle Scholar
  786. Gillespie, J.J., Ayala, A.G., MacKay, B., Silliman, Y.E.: Diagnosis of lymphoma from a cholecystectomy specimen: case report and review of the literature. Sth. med. J. (Bgham, Ala.) 70, 353–354 (1977).Google Scholar
  787. Girard, J.P., Fernandes, B.: Lymphocytes T et B dans les syndromes lymphoprolifératifs. Schweiz. med. Wschr. 105, 1175–1179 (1975).Google Scholar
  788. Givler, R.L.: Involvement of the bladder in leukemia and lymphoma. J. Urol. (Baltimore) 105, 667–670 (1971).Google Scholar
  789. Givler, R.L., Brunk, S.F., Hass, C.A., et al.: Problems of interpretation of liver biopsy in Hodgkin’s disease. Cancer 28, 1335–1342 (1971).PubMedGoogle Scholar
  790. Glatstein, E., Fuks, Z., Goffinet, D.R., Kaplan, H.S.: Non-Hodgkin’s lymphomas of stage III extent. — Is total lymphoid irradiation appropriate treatment? Cancer 37, 2806–2812 (1976).PubMedGoogle Scholar
  791. Glatstein, E., Guernsey, J.M., Rosenberg, S.A., Kaplan, H.S.: The value of laparotomy and splenectomy in the staging of Hodgkin’s disease. Cancer 24, 709 (1969).PubMedGoogle Scholar
  792. Glatstein, E., Kim, H., Donaldson, S.S., Dorfman, R.F., Gribble, T.J., Wilbur, J.R., Rosenberg, S.A., Kaplan, H.S.: Non-Hodgkin’s lymphomas. VI. Results of treatment in childhood. Cancer 34, 204–211 (1974).PubMedGoogle Scholar
  793. Glatstein, E., Trueblood, H.W., Enright, L.P., et al.: Surgical staging of abdominal involvement in unselected patients with Hodgkin’s disease. Radiology 97, 425–432 (1970).PubMedGoogle Scholar
  794. Gluck, M.C., Gallow, G., Lowenstein, J., Baldwin, D.S.: Membranous glomerulonephritis: evolution of clinical and pathological features. Ann. intern. Med. 78, 1 (1973).PubMedGoogle Scholar
  795. Goffinet, D.R., Castellino, R.A., Kim, H., Dorfman, R.F., Fuks, Z., Rosenberg, S.A., Nelson, T., Kaplan, H.S.: Staging laparotomies in unselected previously untreated patients with non-Hodgkin’s lymphomas. Cancer 32, 672–681 (1973).PubMedGoogle Scholar
  796. Goffinet, D.R., Glatskin, E.J., Merigan, T.C.: Herpes zoster-Varicella infection and lymphoma. Ann. intern. Med. 76, 235 (1972).PubMedGoogle Scholar
  797. Goffinet, D.R., Glatstein, E., Fuks, Z., Kaplan, H.S.: Abdominal irradiation in non-Hodgkin’s lymphomas. Cancer 37, 2797–2806 (1976).PubMedGoogle Scholar
  798. Goffinet, D.R., Warnke, R., Dunnick, N.R., Castellino, R., Glatstein, E., Nelsen, T.S., Dorfman, R.F., Rosenberg, S.A., Kaplan, H.S.: Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin’s lymphomas. Cancer Treat. Rep. 61, 981–992 (1977).PubMedGoogle Scholar
  799. Gold, G.L., Shnider, B.I., Salvin, L.G., et al.: The use of mechlorethamine, cyclophosphamide and uracil mustard in neoplastic disease. J. clin. Pharmacol. 10, 110–120 (1970).Google Scholar
  800. Gold, S.B., Schwade, J., Kadin, M.: Lymphoblasts with both T and B cell markers in childhood lymphoproliferative malignancies. AACR Abstr., Toronto 1976.Google Scholar
  801. Golde, D.W., Rothman, B., Cline, M.J.: Production of colony stimulating factor by malignant leukocytes. Blood 43, 749–755 (1974).PubMedGoogle Scholar
  802. Golde, D.W., Quan, S.G., Cline, M.J.: Hairy cell leukemia: in-vitro culture studies. Ann. intern. Med. 85, 78–79 (1976) (Letter).PubMedGoogle Scholar
  803. Golde, D.W., Saxon, A., Stevens, R.H.: Macroglobulinaemia and hairy-cell leukemia. New Engl. J. Med. 296, 92–93 (1977).PubMedGoogle Scholar
  804. Golde, D.W., Saxon, A., Stevens, R.H.: Hairy-cell leukemia. New Engl. J. Med. 296, 882 (1977).Google Scholar
  805. Golde, D.W., Stevens, R.H., Quan, S.G., Saxon, A.: Immunoglobulin synthesis in hairy cell leukaemia. Brit. J. Haemat. 35, 359–365 (1977).PubMedGoogle Scholar
  806. Goldin, A., Venditti, J.M., Kline, I., Mantel, N.: Eradication of leukemic cells (L1210) by methotrexate plus citrovorum factor. Nature 212, 1548–1550 (1966).PubMedGoogle Scholar
  807. Goldman, J.M.: Parasternal chest wall involvement in Hodgkin’s disease. Chest 59, 133–137 (1971).PubMedGoogle Scholar
  808. Goldschneider, I., Grégoire, K.E., Barton, R.W., Bollum, F.J.: Demonstration of terminal deoxynucleotidyl transferase in thymocytes by immunofluorescence. Proc. nat. Acad. Sci. (Wash.) 74, 734–738 (1977).Google Scholar
  809. Goldsmith, M.A., Carter, S.K.: 4′-demethyl-epipodophyllotoxin-B-D-thenylidene glucoside (VM-26). A brief review. Europ. J. Cancer 9, 477 (1973).Google Scholar
  810. Goldstein, E., Hoeprich, P.D.: Lymphangiography in diagnosis of fever of unknown origin. Calif. Med. 119, 59 (1973).PubMedGoogle Scholar
  811. Goldstone, A.H., Cawley, J.C., Roberts, S., Leventine, A., Barker, C.: A case of small cell Sezary’s syndrome with null cell features. J. clin. Path. 29, 848–851 (1976).PubMedGoogle Scholar
  812. Golomb, H.M.: Hairy cell leukemia: An unusual lymphoproliferative disease. Cancer 42, 946–956 (1978).PubMedGoogle Scholar
  813. Golomb, H.M., Braylan, R., Polliack, A.: Hairy cell leukaemia (leukaemic reticuloendotheliosis): a scanning electron microscopic study of eight cases. Brit. J. Haemat. 29, 455–460 (1975).PubMedGoogle Scholar
  814. Golomb, H.M., Braylan, R., Reese C., Variakojis, D., Brynes, R.K., Yachnin, S.: The Sézary syndrome cell: surface ultrastructural characteristics. Acta haematol. 54, 106–114 (1975).PubMedGoogle Scholar
  815. Golomb, H.M., Catovsky, D., Golde, D.W.: Hairy cell leukemia. A clinical review based on 71 cases. Ann. intern. Med. 89, 677 (1978).PubMedGoogle Scholar
  816. Golomb, H.M., Ganapathy, R.: Hairy cells of leukaemic reticuloendotheliosis. Lancet 1976, 39.Google Scholar
  817. Golomb, H.M., Lindgren, V., Rowley, J.D.: Chromosome abnormalities in patients with hairy cell leukemia. Cancer 41, 1374–1380 (1978).PubMedGoogle Scholar
  818. Golomb, H.M., Mintz, U.: Treatment of hairy cell leukemia (leukemic reticuloendotheliosis). II. Chlorambucil therapy in postsplenectomy patients with progressive disease. Blood 54, 305 (1979).PubMedGoogle Scholar
  819. Golomb, H.M., Rowley, J., Vardiman, J., et al.: Partial deletion of the long arm of chromosome 17; A specific abnormality in acute promycelocytic leukemia. Arch, intern. Med. 136, 825 (1976).Google Scholar
  820. Golomb, H.M., Simon, D.: Hairy-cell leukaemia. Lancet 1977, 372–373.Google Scholar
  821. Golomb, H.M., Vardiman, J., Rowley, J.: Acute nonlymphocytic leukemia in adults: Correlations with Q-banded chromosomes. Blood 48, 9 (1976).PubMedGoogle Scholar
  822. Golomb, H.M., Vardiman, J., Sweet, D.L., Simon, D., Variakojis, D.: Hairy cell leukemia: Evidence for the existence of a spectrum of functional characteristics. Brit. J. Haemat. 38, 161–170 (1978).PubMedGoogle Scholar
  823. Golomb, H.M., Vardiman, J., Variakojis, D.: Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: Cytochemical, functional, and clinical correlations. Brit. J. Haemat. 42, 156(1979).Google Scholar
  824. Goonerate, B.W.M.: Lymphography — clinical and experimental. London: Butterworths 1974.Google Scholar
  825. Goor, W., Maier, C., Fierz, W., Ott, F., Pedio, G., Rüttner, J.R., Schmid, W.: The Sézary syndrome. Dermatologica (Basel) 158, 397–403 (1979).Google Scholar
  826. Goos, M.: T-cell specific microenvironment in mycosis fungoides. Arch. Derm. Res. 255, 215–218 (1976).Google Scholar
  827. Goos, M.: Ultrastrukturelle und funktionelle Aspekte maligner Lymphome der Haut. Hautarzt 29, Suppl. III, 15–19 (1978).Google Scholar
  828. Goos, M., Kaiserling, E., Lennert, K.: Mycosis fungoides: model for T-lymphocyte homing to the skin? Brit. J. Derm. 94, 221–222 (1976).PubMedGoogle Scholar
  829. Gordon, J., Howlett, A.R., Smith, J.L.: Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma. Immunology 34, 397–404 (1978).PubMedGoogle Scholar
  830. Gordon, J., Smith, J.L.: Free immunoglobulin light chain synthesis by neoplastic cells in leukaemic reticuloendotheliosis. Clin. exp. Immunol. 31, 244–250 (1978).PubMedGoogle Scholar
  831. Gordon, J.D., Paley, D.H.: Primary malignant tumors of the spleen. Surgery 29, 907–913 (1951).PubMedGoogle Scholar
  832. Gorin, N.-C., David, R., Stachowiak, J., Naiman, A., Duhamel, G.: L’association cyclophosphamide — vincristine — prednisone dans le traitement des lympho- et réticulosarcomes de l’adulte (60 cas). Nouv. Presse méd. 38, 2525–2530 (1976).Google Scholar
  833. Gorin, N.C., David, R., Stachowiak, J., Najman, A., Duhamel, G.: Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin’s lymphomas. Med. Pediatr. Oncol. 3, 41–51 (1977).PubMedGoogle Scholar
  834. Gorski, A., Rokicka-Milewska, R., Lotwin, J., et al.: Clonal proliferation of lymphoid and myeloid progenitor cells in patients with hematological abnormalities. Vox Sang. 37, 84 (1979).PubMedGoogle Scholar
  835. Gottlieb, J.A., Gutterman, J.U., McCredie, K.B., Rodriguez, V., Frei, E. III: Chemotherapy of malignant lymphoma with adriamycin. Cancer Res. 33, 3024–3028 (1973).PubMedGoogle Scholar
  836. Gougerot, H., Burnier, R.: Parapsoriasis en plaques